Next Article in Journal
Biosurfactants Produced by Marine Microorganisms with Therapeutic Applications
Previous Article in Journal
Development of a Rapid Throughput Assay for Identification of hNav1.7 Antagonist Using Unique Efficacious Sodium Channel Agonist, Antillatoxin
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 14
Issue 2
10.3390/md14020037
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Bioactive Compounds Produced by Strains of Penicillium and Talaromyces of Marine Origin

by
Rosario Nicoletti
1,*,† and
Antonio Trincone
2
1
Council for Agricultural Research and Agricultural Economy Analysis, Rome 00184, Italy
2
Institute of Biomolecular Chemistry, National Research Council, Pozzuoli 80078, Italy
*
Author to whom correspondence should be addressed.
†
Current address: Department of Agriculture, University of Naples “Federico II”, Portici 80055, Italy
Mar. Drugs 2016, 14(2), 37; https://doi.org/10.3390/md14020037
Submission received: 23 December 2015 / Revised: 22 January 2016 / Accepted: 25 January 2016 / Published: 18 February 2016
Browse Figures
Versions Notes

Abstract

:
In recent years, the search for novel natural compounds with bioactive properties has received a remarkable boost in view of their possible pharmaceutical exploitation. In this respect the sea is entitled to hold a prominent place, considering the potential of the manifold animals and plants interacting in this ecological context, which becomes even greater when their associated microbes are considered for bioprospecting. This is the case particularly of fungi, which have only recently started to be considered for their fundamental contribution to the biosynthetic potential of other more valued marine organisms. Also in this regard, strains of species which were previously considered typical terrestrial fungi, such as Penicillium and Talaromyces, disclose foreground relevance. This paper offers an overview of data published over the past 25 years concerning the production and biological activities of secondary metabolites of marine strains belonging to these genera, and their relevance as prospective drugs.

Graphical Abstract

1. Introduction

For a long time fungi have been considered as a fundamentally terrestrial form of life. In the past few decades, this concept has started to be revised based on the emerging evidence that these microorganisms are also widespread in the marine habitat. New species recovered from marine substrates are reported repeatedly, which makes a reliable estimate of their actual number quite problematic [1]. Attention of researchers in the field often tends to be focused on the obligate marine species, defined for their ability to grow and sporulate exclusively in a marine habitat [2]. However, it is a matter of fact that many species found at sea are already known from terrestrial contexts, which makes their placement in a “facultative” category more appropriate. It is obvious that the mere isolation from a marine substrate does not imply a real adaptation of a fungus to develop in those particular conditions. Nevertheless, this aspect becomes secondary when considering discovery and exploitation of bioactive compounds, and in view of this objective the ecological versatility of the facultative marine fungi introduces them as being among the most valuable natural resources, deserving to be better characterized through more detailed genetic and biochemical analyses [3].
The issue of bioactive compound production is fundamental in understanding the complex ecological relationships established among and between sea-inhabiting organisms and microorganisms, and presents human nutritional implications due to the possibility that such fungal strains contaminate sea food, and their metabolites eventually act as mycotoxins [4,5]. However, the pharmaceutical industry can be regarded as the application field where products from marine fungi have the most substantial impact, since many of them have entered the clinical pipeline in view of being exploited as novel drugs. Quantitative considerations about fruitfulness in the discovery of new metabolites show that the number of compounds obtained from marine-derived fungi is increasing at a high rate. From a total of about 270 known before 2002, investigations in the field have added more than 800 such products up to 2010 [6], as a result of the availability of bioassay-guided fractionation systems, the accessibility to higher field NMR and mass spectrometers, and the development of the so-called hyphenated spectroscopy technologies (HPLC-MS, HPLC-NMR, etc.) [7]. The recent combining of natural product chemistry and metabolomic approaches in drug discovery can certainly contribute to the development of new leads from marine derived fungi [8].
Within the facultative marine fungi, species of Penicillium and Talaromyces are particularly known for their ability to produce important bioactive compounds. This paper offers an overview of the literature issued in the past 25 years concerning production and biological activities of secondary metabolites of marine strains belonging to the above genera, and their relevance as prospective drugs. Our review basically considers strains obtained from marine sources in a topographic sense, thus possibly including strains/species whose occurrence at sea is merely incidental. Conversely, we did not treat isolates from mangrove plants and their rhizosphere, whose connection with the sea is more remote, and probably deserve a dedicated review. As for the compounds, this overview does not consider primary metabolites mentioned in the cited references, including ergosterol and structurally related compounds [9,10]. Additional exclusions concern other common compounds which often represent intermediates in the synthesis of more complex secondary metabolites, such as orsellinic acid [11,12], and products obtained from mutant strains [13,14,15], or through co-cultivation of two or more strains [16].

2. Penicillium and Talaromyces: An Extraordinary Source of Bioactive Compounds

The Ascomycetous genus Talaromyces (Eurotiomycetes, Trichocomaceae) was initially designated to comprise the teleomorphs of a number of biverticillate Penicillium species. However, following the principle “one fungus—one name” recently affirmed in fungal taxonomy, by which a single holomorphic denomination is to be adopted for species presenting two alternating stages in their life cycle [17], the concept of Talaromyces has been recently extended to include all species in the Penicillium subgenus Biverticillium [18], while the name Penicillium is conserved sensu stricto for species belonging to the subgenera Aspergilloides, Furcatum, and Penicillium, for their associated Eupenicillium teleomorphs, and for species previously classified in a few related genera [19]. Information concerning production of secondary metabolites also supports the separation of the two genera in distinct monophyletic groups based on DNA sequencing [20], and the accumulation of novel data provides a remarkable contribution under the taxonomic viewpoint, particularly in view of a correct species ascription of the many strains which are provisionally reported as Penicillium/Talaromyces sp. [18,21].
Traditionally, species in the genus Penicillium and Talaromyces, which are fundamentally saprophytic and ubiquitary, have been regarded as a fruitful investigational ground for the finding of novel bioactive compounds, leading to the discovery of blockbuster drugs, such as penicillin [22] and the anticholesterolemic agent compactin [23], miscellaneous antitumor products [24], and mycotoxins contaminating food [25]. Most of these fundamental studies were carried out on strains from soil and food commodities. Thus, in a way it is not surprising that the number of bioactive compounds is continuously increasing when a so far inadequately explored context such as the sea has become the subject of systematic investigations. This inference is particularly valid for the species treated in this paper, considering that in a recent review Penicillium is reported as the second most common genus of marine fungi [26]. In our overview we recorded over 550 compounds, or compound families, from a total of about 150 strains belonging to 39 species of Penicillium and five species of Talaromyces (Table 1). Unclassified strains, referred to as Penicillium sp. or Talaromyces sp., represent a remarkable share (ca. 38%), which implies that the number of marine species within these genera is destined to increase when and if more work is carried out on some of these strains, eventually leading to their correct species ascription. With reference to this taxonomic aspect, the characterization of two novel species, Penicillium marinum [25] and Penicillium dravuni [27], deserves to be particularly mentioned.
Concerning sources, 49 strains were recovered from inanimate substrates, mainly sediment and water samples. As for living organisms, sponges appear to be the most widely reported hosts with 33 strains, confirming recent evidence of their significant interaction with fungi [176,177], while the other sources are represented by a disparate set of animals and plants including shellfish, gorgonians and corals, a few tunicate, urchin and fish species, brown, red and green algae, and a single Angiosperm plant (Zostera marina).
About half of the compounds listed in Table 1 (underlined names) were first characterized in strains from marine sources. This remark not only indicates, once again, that sea is a fruitful context for drug discovery, but also introduces a point of view that the ecological relationships established with marine organisms by species which are ordinarily reported from terrestrial environments may somehow address the biochemical pathways toward the synthesis of some peculiar compounds. In this sense, it must be emphasized that a number of unusual molecular structures have been first elucidated from this biological material (Figure 1, Figure 2, Figure 3, Figure 4, Figure 5, Figure 6, Figure 7 and Figure 8).
The rest of the compounds itemized in Table 1 were first extracted and characterized for their bioactivity from terrestrial fungal strains, and a few of them are already known as drugs, or drug prospects. Particularly, mycophenolic acid is famous as the first known fungal antibiotic, discovered as a product of a strain of Penicillium brevicompactum even before the start of the 20th century [178], although its real structure was elucidated only after a few decades [179]. This compound displayed notable antibiotic, antiviral, and cytostatic properties, and has found consistent medical application as an immunosuppressive drug in the derivate form of mycophenolate mofetil [180,181]. First extracted from a strain of Penicillium griseofulvum [182], but later detected in many congeneric species, griseofulvin gained notoriety as an antimycotic drug, and more recently is being considered for its antitumor properties [183]. Again with reference to their antibiotic/cytotoxic properties, gliotoxin and the chaetoglobosins were first characterized from unrelated fungi, respectively Gliocladium fibriatum [184], and Chaetomium globosum [185]. However, both these compounds were later detected in a few Penicillium species, and considered for a series of interesting effects on human tumor cells [24]. Finally, 3-O-methylfunicone was first identified in connection with the antagonistic/mycoparasitic aptitude of the producing strains of Penicillium pinophilum (=Talaromyces pinophilus) [186,187], and later thoroughly characterized for its cytostatic properties on a number of human tumor cell lines, based on effects on cytoskeletal organization, cell cycle progression, the expression of pro-apoptotic genes, the inhibition of markers of tumor progression, and other mechanisms suppressing cell proliferation/migration [188,189,190,191,192,193,194,195,196]. Moreover, remarkable activity as a DNA polymerase inhibitor makes it one of the few known natural compounds displaying this particular effect [83]. Taken together, these valuable biological properties introduce 3-O-methylfunicone as a candidate molecule for more accurate clinical investigations in view of its development as an antitumor drug [197].
With a complex structure based on highly oxygenated, bicyclic and tricyclic frameworks, sorbicillinoids are a class of compounds which include over 50 members [198]. Their name derives from sorbicillin, which was first extracted from a terrestrial strain of Penicillium notatum (=Penicillium chrysogenum) [199]. However, a significant number of analog compounds showing peculiar structural models and consistent bioactive properties have been reported from marine fungi. Producing strains cited in this review were ascribed to a few unrelated species, such as Penicillium citrinum, Penicillium crustosum and Penicillium commune (Table 1). However, authorities in Penicillium taxonomy consider these strains to have been probably misidentified, by reason of strict evidence that these products are typical of P. chrysogenum and allied species [200].
Other products listed in Table 1 are best known for their noxious effects as mycotoxins contaminating foodstuffs. This is the case of cyclopiazonic acid, verrucosidin, fumitremorgin, and a few related tremorgenic toxins, secalonic acids, and particularly of citrinin and patulin [25]. Actually, the concern for dietary intake of mycotoxins produced by Penicillium strains has recently reached seafood, and specific investigations are being carried out in order to better assess the associated risk for consumers [54,128,201].

3. Bioactivities of Novel Compounds

By reason of the quite short time having elapsed after their discovery, most of the novel compounds obtained from marine strains of Penicillium/Talaromyces have been characterized for their biological properties and mechanisms of action only at a preliminary stage. In this regard, the largest category of bioactivity is undoubtedly represented by the cytotoxic/antiproliferative products (Table 2, Figure 1). In fact, assays on human or mammalian cell lines have become widespread following the recent trend to identify new natural antitumor compounds [202], and in view of pursuing this general aim there is a tendency to inappropriately consider these terms as synonyms [203]. Even if such a frequent semantic impropriety does not affect the significance of preliminary bioactivity screenings, the possible relevance of these molecules as antitumor prospects can be introduced only when a further characterization of their cytological effects is accomplished, which quite notably reduces the number of compounds deserving to be further examined in this review.
Besides consistent pro-apoptotic effects on human promyelocytic leukemia cells, the indole diterpenoid alkaloid shearinine E has been characterized for its ability to inhibit the malignant transformation of mouse epidermal cells (JB6P + Cl41) experimentally induced by the epidermal growth factor in the anchorage-independent transformation assay [74].
Another alkaloid with a unique spiro skeleton, penicitrinine A, was found to induce some typical modifications in melanoma cells undergoing apoptosis, such as shrinkage, fragmentation, and chromatin condensation. Assays based on annexin-V/PI double staining showed that apoptosis occurred at a higher rate than control cells treated with the chemotherapeutic drug 5-fluorouracile. Apoptosis followed the mitochondrial pathway, as indicated by down-regulation of the anti-apoptotic gene Bcl-2 and concomitant up-regulation of the pro-apoptotic gene Bax, and the ratio of Bcl-2/Bax expression, which decreased with increasing concentrations of the compound. Anti-metastatic dose-dependent effects were also observed as a result of suppression of invasiveness and inhibition of cell migration, which is an ill-fated tendency of melanoma cells. These latter effects are related to a down-regulation of matrix metalloproteinase (MMP-9) expression along with up-regulation of its inhibitor glycoprotein TIMP-1 [111].
Besides selectively suppressing cell growth and proliferation in five human cancer cell lines, pinophilins displayed a strong inhibitory activity on DNA polymerases of the A-, B-, and Y-families, particularly against DNA pol-α and -κ. The inhibitory effect was selective, since it was not observed on normal human cells (dermal fibroblasts and umbilical vein endothelial cells), possibly because their DNA replication rates are significantly slower than those of cancer cells [122]. Bioactivity as DNA polymerase inhibitors had been previously showed for two phenalenone compounds, the sculezonones A–B. Particularly, both compounds inhibited bovine DNA pol-α and -γ, and moderately affected the activity of DNA pol-ε. Moreover, DNA pol-β was inhibited by sculezonone A, and just weakly influenced by sculezonone B [205]. Another DNA polymerase inhibitor, the γ-lactam compound epolactaene [36], not only was effective on bovine DNA pol-α and rat DNA pol-β, but also disclosed inhibitory properties against human DNA topoisomerase II [206], which is a very important biomolecular mechanism considered in prospecting for antitumor drugs [207]. Consistent neuritogenic effects [36] make this compound even more valuable in view of possible medical applications.
Some degree of neural stimulation was also pointed out for the fellutamides. In fact these tripeptides were characterized as potent enhancers of the release of the nerve growth factor (NGF) from fibroblasts and glial-derived cells [208]. This effect results from the inhibition of proteasome catalytic activity, which leads to increased NGF gene transcription [209]. For different respects, neuroprotective properties have been reported for sorbicillactone A, which impaired the negative effects of important neurotransmitters such as l-glutamic acid and serotonin [62], and brevicompanines E and H (Figure 2), which have been characterized as neuroinflammation modulators [87]. More in detail, in BV2 mouse microglial cells brevicompanine E was found to inhibit production of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), inducible nitric oxides (iNOS), and cyclooxygenase-2 (COX-2), and to reduce the DNA binding activity of the oncogenic nuclear factors AP-1 and NF-κB. Nuclear translocation of the latter was also inhibited, together with IκBα degradation, and Akt and c-Jun NH2-terminal kinase phosphorylation [210]. Similar anti-inflammatory effects were also evidenced in murine peritoneal macrophages for novel ester derivatives of hexylitaconic acid [115], and for penicillinolide A [138] (Figure 2). Weak NF-κB inhibitory properties were again reported from penilactone A [125], while sargassopenilline C has been found to inhibit the transcriptional activity of AP-1 [160] (Figure 2). Finally, and again in BV2 cells, 2E,4Z-tanzawaic acid D was found to inhibit the production of iNOS [158].
Penstyrylpyrone (Figure 2) is another product reported for considerable anti-inflammatory activity deriving from inhibition of the expression of iNOS and COX-2, reduction of TNF-α and IL-1β production, suppression of phosphorylation and degradation of IκB-α, and of NF-κB nuclear translocation and DNA binding activity. These effects were found to be associated with the expression of heme oxygenase 1 (HO-1), an enzyme releasing anti-inflammatory degradation products during heme catabolism. Ultimately, these anti-inflammatory effects lead to a competitive inhibition of the protein tyrosine phosphatase 1B (PTP1B), which is known to play a major role in the negative regulation of insulin signalling. Therefore, this compound was introduced as a prospect therapeutic drug for the treatment of type II diabetes [140]. Inhibitory properties towards PTP1B were also disclosed for penostatins A–C [211], while verruculides A and B respectively displayed a strong and a moderate effect against this enzyme [173]. Finally, a moderate effect as an inhibitor of tyrosine kinases was reported for terrestrol G (Figure 2) [64].
Another target in the search for antitumor products is represented by the reactive oxygen and nitrogen species (ROS), whose excessive production results in oxidative stresses, DNA damage, and inflammation, as well as contributing to tumor initiation and promotion. Consequently, scavenging of the physiologically relevant ROS represents an effective strategy in preventing tumor initiation and promotion. Chromanone A (Figure 3) was characterized as a strong OH scavenger, which also dramatically inhibits the degree of DNA fragmentation. Moreover, it was able to act, in a dose-dependent manner, as a potent inhibitor of cytochrome P4501A, and as an inducer of GSH (cytosolic thiol) and GST enzymes, which both help in the destruction of peroxides, free radicals, and other xenobiotics [86].
Radical scavenging effects were also reported for compound JBIR-59 (Figure 3), on account of its protective effects against l-glutamate toxicity in neuronal hybridoma N18-RE-105 cells [99]. A few more products (Figure 3) have been characterized as free radical scavengers based on their activity against 1,1-diphenyl-2-picrylhydrazyl (DPPH), such as the terrestrols [64], 4,6,4′,6′-tetrabromo-3,3′-dihydroxy-5,5′-dimethyldiphenyl ether and 4,6,2′,4′,6′-pentabromo-3,3′-dihydroxy-5,5′-dimethyldiphenyl ether [105], the variecolorins [102], compound JBIR-124 [100], and sargassopenillines A and E [160]. Further indirect antitumor effects resulting from detoxification of xenobiotics have been proposed for the meroterpenoid penicillipyrone B (Figure 3) for its ability to induce the enzyme quinone-reductase, which is involved in the reduction of electrophilic quinones [151].
Other enzyme modulatory activities are relevant in human medicine for the treatment of a number of complex diseases. This is the case for Alzheimer’s disease, where compounds performing acetylcholinesterase inhibition can be considered in view of possible therapeutic use [212]. In this regard, moderate activity has been reported for products such as sorbiterrin A [65], and penicilliumine [149], while more potent effects have been evidenced for talaromycesone A and talaroxanthenone [161] (Figure 4). The latter compound also showed activity as an inhibitor of phosphodiesterase, which is a target in the treatment of inflammatory processes involved in pulmonary diseases [161]. Besides general activity as inhibitors of proteases, such as papain, ficin, and bromelain, the cathestatins, particularly cathestatin B (Figure 4), were introduced for possible useful effects in the treatment of osteoporosis deriving from the inhibition of bone collagen degradation, and the suppression of calcium release [35]. Finally, along the lines of their more famous analog mycophenolic acid, the penicacids (Figure 4) were investigated for their immunosuppressive properties, and found to possess appreciable inhibitory effects towards inosine-monophosphate dehydrogenase [124].
Antibiotic properties have been assessed for a number of novel compounds (Figure 5) against the bacterial and fungal species indicated in Table 3. Besides these general inhibitory effects, some peculiar mechanisms of action were evidenced for the dipeptide cis-cyclo(leucyl-tyrosyl) (Figure 6), which inhibits biofilm formation by Staphylococcus epidermidis without interfering with bacterial growth [144], and herqueidiketal, which was characterized for inhibitory properties against sortase A of Staphylococcus aureus. Since sortases are absent in mammals, this biochemical effect may be relevant for the development of novel antibiotics [130]. Moreover, the above-mentioned proteasome inhibitory effects by fellutamide B were again observed on Mycobacterium tubercolosis, introducing this peptide as a prospect drug to be more thoroughly investigated against such a deadly pathogen [213].
A few compounds displayed consistent effects against important viruses, such as the influenza virus A (H1N1) and HIV-1. Particularly, the cytopathic effects induced by the former in MDCK cells were found to be inhibited by sorbicathecols A–B (Figure 7) [153], while the latter was impaired by brevione F, which inhibited its replication in C8166 cells [92], and sorbicillactone A, which inhibited the expression of viral proteins and protected H9 cells (human T lymphocytes) against cytopathic effects [62].
Finally, some miscellaneous bioactive effects can be mentioned for a few compounds (Figure 8).
In the search for novel products to be used as additives in antifouling paints used as protective coats for ships’ hulls, potent activities against the larval settlement of barnacles (Balanus amphitrite) were evidenced for 6,8,5′6′-tetrahydroxy-3′-methylflavone [136], and talaromycin C [162].
Widely considered as a model organism used to test the toxicity of chemicals, brine shrimp (Artemia salina) has been employed for demonstrating the toxic effects of products such as 6,7-dihydroxy-3-methoxy-3-methylphthalide [132], 13-O-prenyl-26-hydroxyverruculogen [148], adametizine A [155], the peniciadametizines [156], and the communesins [51]. The latter represent a numerically expanding series of cytochalasan alkaloids which have been also introduced to some extent for cytotoxic/antiproliferative properties (Table 2), and insecticidal effects resulting after oral administration to silkworms [215]. Insect neurotoxicity was also observed in assays carried out on larvae of the bluebottle fly (Calliphora vomitoria) [94]. Moreover, in a study employing a zebra-fish model, communesin I and two more novel compounds, fumiquinazoline Q and protuboxepin E, were reported for cardiotonic effects, as well as some extent of vasculogenetic properties assessed with reference to both number and length of vessels [168].

4. Conclusions

Data summarized in this review highlight the widespread occurrence at sea of Penicillium/Talaromyces strains, and their extraordinary potential as a source of novel bioactive compounds and drugs. As new data accumulate more and more, the awareness is increasing within the scientific community that these microorganisms represent a trove of unexplored biodiversity, and that more exhaustive investigations should be carried out. In this regard, a comprehensive work was recently published concerning diversity and antifungal properties of a group of 184 marine strains belonging to 36 different Penicillium species from Korea [216]. Also a comparison shows that as many as 18 of these species were not even mentioned in our review, which makes it very likely that our proposed record series will be considerably expanded if this biological material is further characterized in order to detect the biochemical determinants of the fungitoxic effects.
In the meantime, much work is to be done with reference to more complete characterization of the biological activities of the material accumulated so far, in view of the increasing number of products which can evolve to the drug level. A good example is represented by sorbicillactone A, whose notable antileukemic effects have stimulated studies for improving its laboratory yields in view of large scale production [217]. However, progress towards this ultimate step is largely dependent on the extent to which the pharmaceutical industry will prove to be prepared to grasp such a great opportunity. It is desirable that the recent policy adopted by most governments worldwide aimed at involving the manufacturing industry in funding for basic research, turns into a more decisive effort, with ensuing results, in this direction.

Acknowledgments

Antonio Trincone acknowledges BENTEN project within the Biotechnology Network of Campania Region (Italy).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Jones, E.B.G.; Pang, K.L. Introduction marine fungi. In Marine Fungi and Fungal-Like Organisms; Walter de Gruyter: Berlin, Germany, 2012; pp. 1–13. [Google Scholar]
  2. Kohlmeyer, J.; Kohlmeyer, E. Marine Mycology: The Higher Fungi; Elsevier: Philadelphia, PA, USA, 2013; p. 704. [Google Scholar]
  3. König, G.M.; Kehraus, S.; Seibert, S.F.; Abdel-Lateff, A.; Müller, D. Natural products from marine organisms and their associated microbes. ChemBioChem 2006, 7, 229–238. [Google Scholar] [CrossRef] [PubMed]
  4. Sallenave-Namont, C.; Pouchus, Y.F.; Du Pont, T.R.; Lassus, P.; Verbist, J.F. Toxigenic saprophytic fungi in marine shellfish farming areas. Mycopathologia 2000, 149, 21–25. [Google Scholar] [CrossRef] [PubMed]
  5. Marrouchi, R.; Benoit, E.; Le Caer, J.P.; Belayouni, N.; Belghith, H.; Molgó, J.; Kharrat, R. Toxic C17-sphinganine analogue mycotoxin, contaminating Tunisian mussels, causes flaccid paralysis in rodents. Mar. Drugs 2013, 11, 4724–4740. [Google Scholar] [CrossRef] [PubMed]
  6. Rateb, M.E.; Ebel, R. Secondary metabolites of fungi from marine habitats. Nat. Prod. Rep. 2011, 28, 290–344. [Google Scholar] [CrossRef] [PubMed]
  7. Baker, D.D.; Chu, M.; Oza, U.; Rajgarhia, V. The value of natural products to future pharmaceutical discovery. Nat. Prod. Rep. 2007, 24, 1225–1244. [Google Scholar] [CrossRef] [PubMed]
  8. Dias, D.A.; Urban, S.; Roessner, U. A historical overview of natural products in drug discovery. Metabolites 2012, 2, 303–336. [Google Scholar] [CrossRef] [PubMed]
  9. Lin, X.; Zhou, X.; Wang, F.; Liu, K.; Yang, B.; Yang, X.; Peng, Y.; Liu, J.; Ren, Z.; Liu, Y. A new cytotoxic sesquiterpene quinone produced by Penicillium sp. F00120 isolated from a deep sea sediment sample. Mar. Drugs 2012, 10, 106–115. [Google Scholar] [CrossRef] [PubMed]
  10. Qi, J.; Shao, C.L.; Liu, M.; Qi, X.; Wang, C.Y. Bioactive steroids from a marine-derived fungus Penicillium sp. from the South China Sea. Chem. Nat. Comp. 2014, 50, 568–570. [Google Scholar] [CrossRef]
  11. Stocker-Wörgötter, E. Metabolic diversity of lichen-forming ascomycetous fungi: Culturing, polyketide and shikimate metabolite production, and PKS genes. Nat. Prod. Rep. 2008, 25, 188–200. [Google Scholar] [CrossRef] [PubMed]
  12. Gao, S.S.; Li, X.M.; Zhang, Y.; Li, C.S.; Cui, C.M.; Wang, B.G. Comazaphilones A–F, azaphilone derivatives from the marine sediment-derived fungus Penicillium commune QSD-17. J. Nat. Prod. 2011, 74, 256–261. [Google Scholar] [CrossRef] [PubMed]
  13. Chai, Y.J.; Cui, C.B.; Li, C.W.; Wu, C.J.; Tian, C.K.; Hua, W. Activation of the dormant secondary metabolite production by introducing gentamicin-resistance in a marine-derived Penicillium purpurogenum G59. Mar. Drugs 2012, 10, 559–582. [Google Scholar] [CrossRef] [PubMed]
  14. Fang, S.M.; Cui, C.B.; Li, C.W.; Wu, C.J.; Zhang, Z.J.; Li, L.; Haung, X.J.; Ye, W.C. Purpurogemutantin and purpurogemutantidin, new drimenyl cyclohexenone derivatives produced by a mutant obtained by diethyl sulfate mutagenesis of a marine-derived Penicillium purpurogenum G59. Mar. Drugs 2012, 10, 1266–1287. [Google Scholar] [CrossRef] [PubMed]
  15. Wu, C.-J.; Li, C.-W.; Cui, C.-B. Seven new and two known lipopeptides as well as five known polyketides: The activated production of silent metabolites in a marine-derived fungus by chemical mutagenesis strategy using diethyl sulphate. Mar. Drugs 2014, 12, 1815–1838. [Google Scholar] [CrossRef] [PubMed]
  16. Chen, H.; Aktas, N.; Konuklugil, B.; Mándi, A.; Daletos, G.; Lin, W.; Dai, H.; Kurtan, T.; Proksch, P. A new fusarielin analogue from Penicillium sp. isolated from the Mediterranean sponge Ircinia oros. Tetrahedron Lett. 2015, 56, 5317–5320. [Google Scholar] [CrossRef]
  17. Taylor, J.W. One fungus = one name: DNA and fungal nomenclature twenty years after PCR. IMA Fungus 2011, 2, 113–120. [Google Scholar] [CrossRef] [PubMed]
  18. Samson, R.A.; Yilmaz, N.; Houbraken, J.; Spierenburg, H.; Seifert, K.A.; Peterson, S.W.; Varga, J.; Frisvad, J.C. Phylogeny and nomenclature of the genus Talaromyces and taxa accommodated in Penicillium subgenus Biverticillium. Stud. Mycol. 2011, 70, 159–183. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Houbraken, J.; Samson, R.A. Phylogeny of Penicillium and the segregation of Trichocomaceae into three families. Stud. Mycol. 2011, 70, 1–51. [Google Scholar] [CrossRef]
  20. Yilmaz, N.; Visagie, C.M.; Houbraken, J.; Frisvad, J.C.; Samson, R.A. Polyphasic taxonomy of the genus Talaromyces. Stud. Mycol. 2014, 78, 175–341. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Frisvad, J.C.; Andersen, B.; Thrane, U. The use of secondary metabolite profiling in chemotaxonomy of filamentous fungi. Mycol. Res. 2008, 112, 231–240. [Google Scholar] [CrossRef] [PubMed]
  22. Demain, A.L.; Elander, R.P. The β-lactam antibiotics: Past, present, and future. Antonie Van Leeuwenhoek 1999, 75, 5–19. [Google Scholar] [CrossRef] [PubMed]
  23. Chakravarti, R.; Sahai, V. Compactin—A review. Appl. Microbiol. Biotechnol. 2004, 64, 618–624. [Google Scholar] [CrossRef] [PubMed]
  24. Nicoletti, R.; Ciavatta, M.L.; Buommino, E.; Tufano, M.A. Antitumor extrolites produced by Penicillium species. Int. J. Biomed. Pharm. Sci. 2008, 2, 1–23. [Google Scholar]
  25. Frisvad, J.C.; Smedsgaard, J.; Larsen, T.O.; Samson, R.A. Mycotoxins, drugs and other extrolites produced by species in Penicillium subgenus Penicillium. Stud. Mycol. 2004, 49, 201–241. [Google Scholar]
  26. Jones, E.G.; Suetrong, S.; Sakayaroj, J.; Bahkali, A.H.; Abdel-Wahab, M.A.; Boekhout, T.; Pang, K.L. Classification of marine Ascomycota, Basidiomycota, Blastocladiomycota and Chytridiomycota. Fungal Diver. 2015, 73, 1–72. [Google Scholar] [CrossRef]
  27. Janso, J.E.; Bernan, V.S.; Greenstein, M.; Bugni, T.S.; Ireland, C.M. Penicillium dravuni, a new marine-derived species from an alga in Fiji. Mycologia 2005, 97, 444–453. [Google Scholar] [CrossRef] [PubMed]
  28. Shigemori, H.; Wakuri, S.; Yazawa, K.; Nakamura, T.; Sasaki, T.; Kobayashi, J. Fellutamides A and B, cytotoxic peptides from a marine fish-possessing fungus Penicillium fellutanum. Tetrahedron 1991, 47, 8529–8534. [Google Scholar] [CrossRef]
  29. Numata, A.; Takahashi, C.; Ito, Y.; Takada, T.; Kawai, K.; Usami, Y.; Matsumura, E.; Imachi, M.; Ito, T.; Hasegawa, T. Communesins, cytotoxic metabolites of a fungus isolated from a marine alga. Tetrahedron Lett. 1993, 34, 2355–2358. [Google Scholar] [CrossRef]
  30. Numata, A.; Takahashi, C.; Ito, Y.; Minoura, K.; Yamada, T.; Matsuda, C.; Nomoto, K. Penochalasins, a novel class of cytotoxic cytochalasans from a Penicillium species separated from a marine alga: Structure determination and solution conformation. J. Chem. Soc. Perkin Trans. 1996, 239–245. [Google Scholar] [CrossRef]
  31. Takahashi, C.; Numata, A.; Yamada, T.; Minoura, K.; Enomoto, S.; Konishi, K.; Nakai, M.; Matsuda, C.; Nomoto, K. Penostatins, novel cytotoxic metabolites from a Penicillium species separated from a green alga. Tetrahedron Lett. 1996, 37, 655–658. [Google Scholar] [CrossRef]
  32. Iwamoto, C.; Minoura, K.; Oka, T.; Ohta, T.; Hagishita, S.; Numata, A. Absolute stereostructures of novel cytotoxic metabolites, penostatins A–E, from a Penicillium species separated from an Enteromorpha alga. Tetrahedron 1999, 55, 14353–14368. [Google Scholar] [CrossRef]
  33. Iwamoto, C.; Minoura, K.; Hagishita, S.; Nomoto, K.; Numata, A. Penostatins F–I, novel cytotoxic metabolites from a Penicillium species separated from an Enteromorpha marine alga. J. Chem. Soc. Perkin Trans. 1998, 449–456. [Google Scholar] [CrossRef]
  34. Iwamoto, C.; Yamada, T.; Ito, Y.; Minoura, K.; Numata, A. Cytotoxic cytochalasans from a Penicillium species separated from a marine alga. Tetrahedron 2001, 57, 2997–3004. [Google Scholar] [CrossRef]
  35. Woo, J.T.; Ono, H.; Tsuji, T. Cathestatins, new cysteine protease inhibitors produced by Penicillium citrinum. Biosci. Biotechnol. Biochem. 1995, 59, 350–352. [Google Scholar] [CrossRef] [PubMed]
  36. Kakeya, H.; Takahashi, I.; Okada, G.; Isono, K.; Osada, H. Epolactaene, a novel neuritogenic compound in human neuroblastoma cells, produced by a marine fungus. J. Antibiot. 1995, 48, 733–735. [Google Scholar] [CrossRef] [PubMed]
  37. Cui, C.B.; Usukata, M.; Kakeya, H.; Onose, R.; Okada, G.; Takahashi, I.; Isono, K.; Osada, H. Acetophthalidin, a novel inhibitor of mammalian cell cycle, produced by a fungus isolated from a sea sediment. J. Antibiot. 1996, 49, 216–219. [Google Scholar] [CrossRef] [PubMed]
  38. Cabrera, G.M.; Seldes, A.M. Citrinin derivatives from an intertidal marine Penicillium. An. Asoc. Quim. Argent. 1997, 85, 193–196. [Google Scholar]
  39. Onuki, H.; Miyashige, H.; Hasegawa, H.; Yamashita, S. NI15501A, a novel anthranilamide derivative from a marine fungus Penicillium sp. J. Antibiot. 1998, 51, 442–444. [Google Scholar] [CrossRef] [PubMed]
  40. Amagata, T.; Minoura, K.; Numata, A. Cytotoxic metabolites produced by a fungal strain from a Sargassum alga. J. Antibiot. 1998, 51, 432–434. [Google Scholar] [CrossRef]
  41. Christophersen, C.; Crescente, O.; Frisvad, J.C.; Gram, L.; Nielsen, J.; Nielsen, P.H.; Rahbæk, L. Antibacterial activity of marine-derived fungi. Mycopathologia 1998, 143, 135–138. [Google Scholar] [CrossRef] [PubMed]
  42. Malmstrøm, J.; Christophersen, C.; Frisvad, J.C. Secondary metabolites characteristic of Penicillium citrinum, Penicillium steckii and related species. Phytochemistry 2000, 54, 301–309. [Google Scholar] [CrossRef]
  43. Son, B.W.; Jensen, P.R.; Kauffman, C.A.; Fenical, W. New cytotoxic epidithiodioxopiperazines related to verticillin A from a marine isolate of the fungus Penicillium. Nat. Prod. Lett. 1999, 13, 213–222. [Google Scholar] [CrossRef]
  44. Kagata, T.; Shigemori, H.; Mikami, Y.; Kobayashi, J. Coruscol A, a new metabolite from the marine-derived fungus Penicillium species. J. Nat. Prod. 2000, 63, 886–887. [Google Scholar] [CrossRef]
  45. Komatsu, K.; Shigemori, H.; Mikami, Y.; Kobayashi, J. Sculezonones A and B, two metabolites possessing a phenalenone skeleton from a marine-derived fungus Penicillium species. J. Nat. Prod. 2000, 63, 408–409. [Google Scholar] [CrossRef] [PubMed]
  46. Lin, Y.; Shao, Z.; Jiang, G.; Zhou, S.; Cai, J.; Vrijmoed, L.L.P.; Jones, E.G. Penicillazine, a unique quinolone derivative with 4H-5, 6-dihydro-1, 2-oxazine ring system from the marine fungus Penicillium sp. (strain# 386) from the South China Sea. Tetrahedron 2000, 56, 9607–9609. [Google Scholar]
  47. Edrada, R.A.; Heubes, M.; Brauers, G.; Wray, V.; Berg, A.; Gräfe, U.; Wohlfarth, M.; Mühlbacher, J.; Schaumann, K.; Sudarsono, S.; et al. Online analysis of xestodecalactones A–C, novel bioactive metabolites from the fungus Penicillium cf. montanense and their subsequent isolation from the sponge Xestospongia exigua. J. Nat. Prod. 2002, 65, 1598–1604. [Google Scholar] [PubMed]
  48. Amagata, T.; Amagata, A.; Tenney, K.; Valeriote, F.A.; Lobkovsky, E.; Clardy, J.; Crews, P. Unusual C25 steroids produced by a sponge-derived Penicillium citrinum. Org. Lett. 2003, 5, 4393–4396. [Google Scholar] [CrossRef] [PubMed]
  49. Bugni, T.S.; Bernan, V.S.; Greenstein, M.; Janso, J.E.; Maiese, W.M.; Mayne, C.L.; Ireland, C.M. Brocaenols A–C: Novel polyketides from a marine-derived Penicillium brocae. J. Org. Chem. 2003, 68, 2014–2017. [Google Scholar] [CrossRef] [PubMed]
  50. Bugni, T.S.; Janso, J.E.; Williamson, R.T.; Feng, X.; Bernan, V.S.; Greenstein, M.; Carter, G.T.; Maiese, W.M.; Ireland, C.M. Dictyosphaeric acids A and B: New decalactones from an undescribed Penicillium sp. obtained from the alga Dictyosphaeria versluyii. J. Nat. Prod. 2004, 67, 1396–1399. [Google Scholar] [CrossRef] [PubMed]
  51. Jadulco, R.; Edrada, R.A.; Ebel, R.; Berg, A.; Schaumann, K.; Wray, V.; Steube, K.; Proksch, P. New communesin derivatives from the fungus Penicillium sp. derived from the Mediterranean sponge Axinella verrucosa. J. Nat. Prod. 2004, 67, 78–81. [Google Scholar] [CrossRef] [PubMed]
  52. Bringmann, G.; Lang, G.; Steffens, S.; Schaumann, K. Petrosifungins A and B, novel cyclodepsipeptides from a sponge-derived strain of Penicillium brevicompactum. J. Nat. Prod. 2004, 67, 311–315. [Google Scholar] [CrossRef] [PubMed]
  53. Gautschi, J.T.; Amagata, T.; Amagata, A.; Valeriote, F.A.; Mooberry, S.L.; Crews, P. Expanding the strategies in natural product studies of marine-derived fungi: A chemical investigation of Penicillium obtained from deep water sediment. J. Nat. Prod. 2004, 67, 362–367. [Google Scholar] [CrossRef] [PubMed]
  54. Vansteelandt, M.; Kerzaon, I.; Blanchet, E.; Tankoua, O.F.; Du Pont, T.R.; Joubert, Y.; Monteau, F.; Le Bizec, B.; Frisvad, J.C.; Pouchus, Y.F.; et al. Patulin and secondary metabolite production by marine-derived Penicillium strains. Fungal Biol. 2012, 116, 954–961. [Google Scholar] [CrossRef] [PubMed]
  55. Petit, K.E.; Mondeguer, F.; Roquebert, M.F.; Biard, J.F.; Pouchus, Y.F. Detection of griseofulvin in a marine strain of Penicillium waksmanii by ion trap mass spectrometry. J. Microbiol. Meth. 2004, 58, 59–65. [Google Scholar] [CrossRef]
  56. Vansteelandt, M.; Blanchet, E.; Egorov, M.; Petit, F.; Toupet, L.; Bondon, A.; Monteau, F.; Le Bizec, B.; Thomas, O.; Pouchus, Y.F.; et al. Ligerin, an antiproliferative chlorinated sesquiterpenoid from a marine-derived Penicillium strain. J. Nat. Prod. 2013, 76, 297–301. [Google Scholar] [CrossRef] [PubMed]
  57. Tsuda, M.; Kasai, Y.; Komatsu, K.; Sone, T.; Tanaka, M.; Mikami, Y.; Kobayashi, J. Citrinadin A, a novel pentacyclic alkaloid from marine-derived fungus Penicillium citrinum. Org. Lett. 2004, 6, 3087–3089. [Google Scholar] [CrossRef] [PubMed]
  58. Mugishima, T.; Tsuda, M.; Kasai, Y.; Ishiyama, H.; Fukushi, E.; Kawabata, J.; Watanabe, M.; Akao, K.; Kobayashi, J. Absolute stereochemistry of citrinadins A and B from marine-derived fungus. J. Org. Chem. 2005, 70, 9430–9435. [Google Scholar] [CrossRef] [PubMed]
  59. Sasaki, M.; Tsuda, M.; Sekiguchi, M.; Mikami, Y.; Kobayashi, J. Perinadine A, a novel tetracyclic alkaloid from marine-derived fungus Penicillium citrinum. Org. Lett. 2005, 7, 4261–4264. [Google Scholar] [CrossRef] [PubMed]
  60. Tsuda, M.; Sasaki, M.; Mugishima, T.; Komatsu, K.; Sone, T.; Tanaka, M.; Mikami, Y.; Kobayashi, J. Scalusamides AC, new pyrrolidine alkaloids from the marine-derived fungus Penicillium citrinum. J. Nat. Prod. 2005, 68, 273–276. [Google Scholar] [CrossRef] [PubMed]
  61. He, J.; Lion, U.; Sattler, I.; Gollmick, F.A.; Grabley, S.; Cai, J.; Meiners, M.; Schünke, H.; Schaumann, K.; Dechert, U.; et al. Diastereomeric quinolinone alkaloids from the marine-derived fungus Penicillium janczewskii. J. Nat. Prod. 2005, 68, 1397–1399. [Google Scholar] [CrossRef]
  62. Bringmann, G.; Lang, G.; Gulder, T.A.M.; Hideyuki, H.; Mühlbacher, J.; Maksimenka, K.; Steffens, S.; Schaumann, K.; Stöhr, R.; Wiese, J.; et al. The first sorbicillinoid alkaloids, the antileukemic sorbicillactones A and B, from a sponge derived Penicillium chrysogenum strain. Tetrahedron 2005, 61, 7252–7265. [Google Scholar] [CrossRef]
  63. Bringmann, G.; Lang, G.; Bruhn, T.; Schäffler, K.; Steffens, S.; Schmaljohann, R.; Wiese, J.; Imhoff, J.F. Sorbifuranones A–C, sorbicillinoid metabolites from Penicillium strains isolated from Mediterranean sponges. Tetrahedron 2010, 66, 9894–9901. [Google Scholar] [CrossRef]
  64. Chen, L.; Fang, Y.; Zhu, T.; Gu, Q.; Zhu, W. Gentisyl alcohol derivatives from the marine-derived fungus Penicillium terrestre. J. Nat. Prod. 2008, 71, 66–70. [Google Scholar] [CrossRef] [PubMed]
  65. Chen, L.; Zhu, T.; Ding, Y.; Khan, I.A.; Gu, Q.; Li, D. Sorbiterrin A, a novel sorbicillin derivative with cholinesterase inhibition activity from the marine-derived fungus Penicillium terrestre. Tetrahedron Lett. 2012, 53, 325–328. [Google Scholar] [CrossRef]
  66. Liu, W.; Gu, Q.; Zhu, W.; Cui, C.; Fan, G. Dihydrotrichodimerol and tetrahydrotrichodimerol, two new bisorbicillinoids, from a marine-derived Penicillium terrestre. J. Antibiot. 2005, 58, 621–624. [Google Scholar] [CrossRef]
  67. Liu, W.; Gu, Q.; Zhu, W.; Cui, C.; Fan, G. Two new benzoquinone derivatives and two new bisorbicillinoids were isolated from a marine-derived fungus Penicillium terrestre. J. Antibiot. 2005, 58, 441–446. [Google Scholar] [CrossRef] [PubMed]
  68. Liu, W.; Gu, Q.; Zhu, W.; Cui, C.; Fan, G.; Zhu, T.; Liu, H.; Fang, Y. Penicillones A and B, two novel polyketides with tricyclo [5.3.1.0.3.8] undecane skeleton, from a marine-derived fungus Penicillium terrestre. Tetrahedron Lett. 2005, 46, 4993–4996. [Google Scholar] [CrossRef]
  69. Li, D.; Chen, L.; Zhu, T.; Kurtán, T.; Mándi, A.; Zhao, Z.; Li, J.; Gu, Q. Chloctanspirones A and B, novel chlorinated polyketides with an unprecedented skeleton, from marine sediment derived fungus Penicillium terrestre. Tetrahedron 2011, 67, 7913–7918. [Google Scholar] [CrossRef]
  70. Xue, C.; Li, T.; Deng, Z.; Fu, H.; Lin, W. Janthinolide A–B, two new 2,5-piperazinedione derivatives from the endophytic Penicillium janthinellum isolated from the soft coral Dendronephthya sp. Pharmazie 2006, 61, 1041–1044. [Google Scholar] [CrossRef]
  71. Rovirosa, J.; Diaz-Marrero, A.N.A.; Darías, J.; Painemal, K.; San Martín, A. Secondary metabolites from marine Penicillium brevicompactum. J. Chil. Chem. Soc. 2006, 51, 775–778. [Google Scholar] [CrossRef]
  72. Lang, G.; Wiese, J.; Schmaljohann, R.; Imhoff, J.F. New pentaenes from the sponge-derived marine fungus Penicillium rugulosum: Structure determination and biosynthetic studies. Tetrahedron 2007, 63, 11844–11849. [Google Scholar] [CrossRef]
  73. El-Beih, A.A.; Kato, H.; Tsukamoto, S.; Ohta, T. CYP3A4 inhibitors isolated from a marine derived fungus Penicillium species. J. Nat. Med. 2007, 61, 175–177. [Google Scholar] [CrossRef]
  74. Smetanina, O.F.; Kalinovsky, A.I.; Khudyakova, Y.V.; Pivkin, M.V.; Dmitrenok, P.S.; Fedorov, S.N.; Ji, H.; Kwak, J.-Y.; Kuznetsova, T.A. Indole alkaloids produced by a marine fungus isolate of Penicillium janthinellum Biourge. J. Nat. Prod. 2007, 70, 906–909. [Google Scholar] [CrossRef] [PubMed]
  75. Capon, R.J.; Stewart, M.; Ratnayake, R.; Lacey, E.; Gill, J.H. Citromycetins and bilains A–C: New aromatic polyketides and diketopiperazines from Australian marine-derived and terrestrial Penicillium spp. J. Nat. Prod. 2007, 70, 1746–1752. [Google Scholar] [CrossRef] [PubMed]
  76. Zhang, D.; Li, X.; Kang, J.S.; Choi, H.D.; Jung, J.H.; Son, B.W. Redoxcitrinin, a biogenetic precursor of citrinin from marine isolate of fungus Penicillium sp. J. Microbiol. Biotechnol. 2007, 17, 865–867. [Google Scholar] [PubMed]
  77. Xin, Z.; Fang, Y.; Du, L.; Zhu, T.; Duan, L.; Chen, J.; Gu, Q.; Zhu, W. Aurantiomides A–C, quinazoline alkaloids from the sponge-derived fungus Penicillium aurantiogriseum SP0-19. J. Nat. Prod. 2007, 70, 853–855. [Google Scholar] [CrossRef] [PubMed]
  78. Xin, Z.H.; Zhu, T.J.; Wang, W.L.; Du, L.; Fang, Y.C.; Gu, Q.Q.; Zhu, W.M. Isocoumarin derivatives from the sea squirt-derived fungus Penicillium stoloniferum QY2-10 and the halotolerant fungus Penicillium notatum B-52. Arch. Pharm. Res. 2007, 30, 816–819. [Google Scholar] [CrossRef] [PubMed]
  79. Ren, H.; Gu, Q.Q.; Cui, C.B. Anthraquinone derivatives produced by marine-derived Penicillium flavidorsum SHK1-27 and their antitumor activities. Chin. J. Med. Chem. 2007, 17, 148–154. [Google Scholar]
  80. Iida, M.; Ooi, T.; Kito, K.; Yoshida, S.; Kanoh, K.; Shizuri, Y.; Kusumi, T. Three new polyketide-terpenoid hybrids from Penicillium sp. Org. Lett. 2008, 10, 845–848. [Google Scholar] [CrossRef] [PubMed]
  81. Huang, Y.F.; Qiao, L.; Lv, A.L.; Pei, Y.H.; Tian, L. Eremophilane sesquiterenes from the marine fungus Penicillium sp. BL27-2. Chin. Chem. Lett. 2008, 19, 562–564. [Google Scholar] [CrossRef]
  82. Motohashi, K.; Hashimoto, J.; Inaba, S.; Khan, S.T.; Komaki, H.; Nagai, A.; Takagi, M.; Shin-ya, K. New sesquiterpenes, JBIR-27 and-28, isolated from a tunicate-derived fungus, Penicillium sp. SS080624SCf1. J. Antibiot. 2009, 62, 247–250. [Google Scholar] [CrossRef] [PubMed]
  83. Mizushina, Y.; Motoshima, H.; Yamaguchi, Y.; Takeuchi, T.; Hirano, K.; Sugawara, F.; Yoshida, H. 3-O-methylfunicone, a selective inhibitor of mammalian Y-family DNA polymerases from an Australian sea salt fungal strain. Mar. Drugs 2009, 7, 624–639. [Google Scholar] [CrossRef] [PubMed]
  84. De Silva, E.D.; Geiermann, A.S.; Mitova, M.I.; Kuegler, P.; Blunt, J.W.; Cole, A.L.; Munro, M.H. Isolation of 2-pyridone alkaloids from a New Zealand marine-derived Penicillium species. J. Nat. Prod. 2009, 72, 477–479. [Google Scholar] [CrossRef] [PubMed]
  85. Zhu, T.J.; Du, L.; Hao, P.F.; Lin, Z.J.; Gu, Q.Q. Citrinal A, a novel tricyclic derivative of citrinin, from an algicolous fungus Penicillium sp. i-1-1. Chin. Chem. Lett. 2009, 20, 917–920. [Google Scholar] [CrossRef]
  86. Gamal-Eldeen, A.M.; Abdel-Lateff, A.; Okino, T. Modulation of carcinogen metabolizing enzymes by chromanone A; a new chromone derivative from algicolous marine fungus Penicillium sp. Environ. Toxicol. Pharmacol. 2009, 28, 317–322. [Google Scholar] [CrossRef] [PubMed]
  87. Du, L.; Yang, X.; Zhu, T.; Wang, F.; Xiao, X.; Park, H.; Gu, Q. Diketopiperazine alkaloids from a deep ocean sediment derived fungus Penicillium sp. Chem. Pharm. Bull. 2009, 57, 873–876. [Google Scholar] [CrossRef] [PubMed]
  88. Du, L.; Li, D.; Zhu, T.; Cai, S.; Wang, F.; Xiao, X.; Gu, Q. New alkaloids and diterpenes from a deep ocean sediment derived fungus Penicillium sp. Tetrahedron 2009, 65, 1033–1039. [Google Scholar] [CrossRef]
  89. Du, L.; Feng, T.; Zhao, B.; Li, D.; Cai, S.; Zhu, T.; Wang, F.; Xiao, X.; Gu, Q. Alkaloids from a deep ocean sediment-derived fungus Penicillium sp. and their antitumor activities. J. Antibiot. 2010, 63, 165–170. [Google Scholar] [CrossRef] [PubMed]
  90. Guo, W.; Peng, J.; Zhu, T.; Gu, Q.; Keyzers, R.A.; Li, D. Sorbicillamines A–E, nitrogen-containing sorbicillinoids from the deep-sea-derived fungus Penicillium sp. F23-2. J. Nat. Prod. 2013, 76, 2106–2112. [Google Scholar] [CrossRef] [PubMed]
  91. Guo, W.; Zhang, Z.; Zhu, T.; Gu, Q.; Li, D. Penicyclones A–E, antibacterial polyketides from the deep-sea-derived fungus Penicillium sp. F23-2. J. Nat. Prod. 2015, 78, 2699–2703. [Google Scholar] [CrossRef] [PubMed]
  92. Li, Y.; Ye, D.; Chen, X.; Lu, X.; Shao, Z.; Zhang, H.; Che, Y. Breviane spiroditerpenoids from an extreme-tolerant Penicillium sp. isolated from a deep sea sediment sample. J. Nat. Prod. 2009, 72, 912–916. [Google Scholar] [CrossRef] [PubMed]
  93. Li, Y.; Ye, D.; Shao, Z.; Cui, C.; Che, Y. A sterol and spiroditerpenoids from a Penicillium sp. isolated from a deep sea sediment sample. Mar. Drugs 2012, 10, 497–508. [Google Scholar] [CrossRef] [PubMed]
  94. Kerzaon, I.; Pouchus, Y.F.; Monteau, F.; Le Bizec, B.; Nourrisson, M.R.; Biard, J.F.; Grovel, O. Structural investigation and elucidation of new communesins from a marine-derived Penicillium expansum Link by liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 2009, 23, 3928–3938. [Google Scholar] [CrossRef]
  95. Trisuwan, K.; Rukachaisirikul, V.; Sukpondma, Y.; Phongpaichit, S.; Preedanon, S.; Sakayaroj, J. Lactone derivatives from the marine-derived fungus Penicillium sp. PSU-F44. Chem. Pharm. Bull. 2009, 57, 1100–1102. [Google Scholar] [CrossRef] [PubMed]
  96. Trisuwan, K.; Rukachaisirikul, V.; Sukpondma, Y.; Phongpaichit, S.; Preedanon, S.; Sakayaroj, J. Furo[3,2-h]isochroman, furo[3,2-h]isoquinoline, isochroman, phenol, pyranone, and pyrone derivatives from the sea fan-derived fungus Penicillium sp. PSU-F40. Tetrahedron 2010, 66, 4484–4489. [Google Scholar] [CrossRef]
  97. Liu, S.; Yan, X.; Yu, M.; Chen, J.; Zhang, L. A novel compound from Penicillium sp. (M207142). Chem. Nat. Comp. 2010, 46, 116–118. [Google Scholar] [CrossRef]
  98. Wiese, J.; Ohlendorf, B.; Blümel, M.; Schmaljohann, R.; Imhoff, J.F. Phylogenetic identification of fungi isolated from the marine sponge Tethya aurantium and identification of their secondary metabolites. Mar. Drugs 2011, 9, 561–585. [Google Scholar] [CrossRef]
  99. Ueda, J.Y.; Hashimoto, J.; Inaba, S.; Takagi, M.; Shin-ya, K. JBIR-59, a new sorbicillinoid, from a marine-derived fungus Penicillium citrinum SpI080624G1f01. J. Antibiot. 2010, 63, 203–205. [Google Scholar] [CrossRef] [PubMed]
  100. Kawahara, T.; Takagi, M.; Shin-ya, K. JBIR-124: A novel antioxidative agent from a marine sponge-derived fungus Penicillium citrinum SpI080624G1f01. J. Antibiot. 2012, 65, 45–47. [Google Scholar] [CrossRef] [PubMed]
  101. Pimenta, E.F.; Vita-Marques, A.M.; Tininis, A.; Seleghim, M.H.R.; Sette, L.D.; Veloso, K.; Ferreira, A.G.; Williams, D.E.; Patrick, B.O.; Dalisay, D.S.; et al. Use of experimental design for the optimization of the production of new secondary metabolites by two Penicillium species. J. Nat. Prod. 2010, 73, 1821–1832. [Google Scholar] [CrossRef] [PubMed]
  102. Zhou, L.N.; Zhu, T.J.; Cai, S.X.; Gu, Q.Q.; Li, D.H. Three new indole-containing diketopiperazine alkaloids from a deep-ocean sediment derived fungus Penicillium griseofulvum. Helv. Chim. Acta 2010, 93, 1758–1763. [Google Scholar] [CrossRef]
  103. Yu, K.; Ren, B.; Wei, J.; Chen, C.; Sun, J.; Song, F.; Dai, H.; Zhang, L. Verrucisidinol and verrucosidinol acetate, two pyrone-type polyketides isolated from a marine derived fungus, Penicillium aurantiogriseum. Mar. Drugs 2010, 8, 2744–2754. [Google Scholar] [CrossRef] [PubMed]
  104. Song, F.; Ren, B.; Yu, K.; Chen, C.; Guo, H.; Yang, N.; Gao, H.; Liu, X.; Liu, M.; Tong, Y.; et al. Quinazolin-4-one coupled with pyrrolidin-2-iminium alkaloids from marine-derived fungus Penicillium aurantiogriseum. Mar. Drugs 2012, 10, 1297–1306. [Google Scholar] [CrossRef] [PubMed]
  105. Yang, G.; Yun, K.; Nenkep, V.N.; Choi, H.D.; Kang, J.S.; Son, B.W. Induced production of halogenated diphenyl ethers from the marine-derived fungus Penicillium chrysogenum. Chem. Biodivers. 2010, 7, 2766–2770. [Google Scholar] [CrossRef] [PubMed]
  106. Meyer, S.W.; Mordhorst, T.F.; Lee, C.; Jensen, P.R.; Fenical, W.; Köck, M. Penilumamide, a novel lumazine peptide isolated from the marine-derived fungus, Penicillium sp. CNL-338. Org. Biomol. Chem. 2010, 8, 2158–2163. [Google Scholar] [CrossRef] [PubMed]
  107. Gao, S.S.; Li, X.M.; Du, F.Y.; Li, C.S.; Proksch, P.; Wang, B.G. Secondary metabolites from a marine-derived endophytic fungus Penicillium chrysogenum QEN-24S. Mar. Drugs 2011, 9, 59–70. [Google Scholar] [CrossRef] [PubMed]
  108. Gao, S.S.; Li, X.M.; Li, C.S.; Proksch, P.; Wang, B.G. Penicisteroids A and B, antifungal and cytotoxic polyoxygenated steroids from the marine alga-derived endophytic fungus Penicillium chrysogenum QEN-24S. Bioorg. Med. Chem. Lett. 2011, 21, 2894–2897. [Google Scholar] [CrossRef] [PubMed]
  109. Gao, S.S.; Li, X.M.; Zhang, Y.; Li, C.S.; Wang, B.G. Conidiogenones H and I, two new diterpenes of cyclopiane class from a marine-derived endophytic fungus Penicillium chrysogenum QEN-24S. Chem. Biodivers. 2011, 8, 1748–1753. [Google Scholar] [CrossRef] [PubMed]
  110. Smetanina, O.F.; Yurchenko, A.N.; Kalinovsky, A.I.; Pushilin, M.A.; Slinkina, N.N.; Yurchenko, E.A.; Afiyatullov, S.S. 4-Methoxy-3-methylgoniothalamin from marine-derived fungi of the genus Penicillium. Russ. Chem. Bull. 2011, 60, 760–763. [Google Scholar] [CrossRef]
  111. Liu, Q.Y.; Zhou, T.; Zhao, Y.Y.; Chen, L.; Gong, M.W.; Xia, Q.W.; Ying, M.G.; Zheng, Q.H.; Zhang, Q.Q. Antitumor effects and related mechanisms of penicitrinine A, a novel alkaloid with a unique spiro skeleton from the marine fungus Penicillium citrinum. Mar. Drugs 2015, 13, 4733–4753. [Google Scholar] [CrossRef] [PubMed]
  112. Chen, L.; Liu, W.; Hu, X.; Huang, K.; Wu, J.L.; Zhang, Q.Q. Citrinin derivatives from the marine-derived fungus Penicillium citrinum. Chem. Pharm. Bull. 2011, 59, 515–517. [Google Scholar] [CrossRef] [PubMed]
  113. Chen, L.; Gong, M.-W.; Peng, Z.-F.; Zhou, T.; Ying, M.-G.; Zheng, Q.-H.; Liu, Q.-Y.; Zhang, Q.Q. The marine fungal metabolite, dicitrinone B, induces A375 cell apoptosis through the ROS-related caspase pathway. Mar. Drugs 2014, 12, 1939–1958. [Google Scholar] [CrossRef] [PubMed]
  114. Sun, Y.; Takada, K.; Takemoto, Y.; Yoshida, M.; Nogi, Y.; Okada, S.; Matsunaga, S. Gliotoxin analogues from a marine-derived fungus, Penicillium sp., and their cytotoxic and histone methyltransferase inhibitory activities. J. Nat. Prod. 2011, 75, 111–114. [Google Scholar] [CrossRef] [PubMed]
  115. Li, J.L.; Zhang, P.; Lee, Y.M.; Hong, J.; Yoo, E.S.; Bae, K.S.; Jung, J.H. Oxygenated hexylitaconates from a marine sponge-derived fungus Penicillium sp. Chem. Pharm. Bull. 2011, 59, 120–123. [Google Scholar] [CrossRef] [PubMed]
  116. Li, C.S.; An, C.Y.; Li, X.M.; Gao, S.S.; Cui, C.M.; Sun, H.F.; Wang, B.G. Triazole and dihydroimidazole alkaloids from the marine sediment-derived fungus Penicillium paneum SD-44. J. Nat. Prod. 2011, 74, 1331–1334. [Google Scholar] [CrossRef]
  117. Li, C.S.; Li, X.M.; Gao, S.S.; Lu, Y.H.; Wang, B.G. Cytotoxic anthranilic acid derivatives from deep sea sediment-derived fungus Penicillium paneum SD-44. Mar. Drugs 2013, 11, 3068–3076. [Google Scholar] [CrossRef] [PubMed]
  118. Li, C.; Li, X.; An, C.; Wang, B. Prenylated indole alkaloid derivatives from marine sediment-derived fungus Penicillium paneum SD-44. Helv. Chim. Acta 2014, 97, 1440–1444. [Google Scholar] [CrossRef]
  119. Gao, S.S.; Shang, Z.; Li, X.M.; Li, C.S.; Cui, C.M.; Wang, B.G. Secondary metabolites produced by solid fermentation of the marine-derived fungus Penicillium commune QSD-17. Biosci. Biotechnol. Biochem. 2012, 76, 358–360. [Google Scholar] [CrossRef] [PubMed]
  120. Kossuga, M.H.; Romminger, S.; Xavier, C.; Milanetto, M.C.; do Valle, M.Z.; Pimenta, E.F.; Morais, R.P.; de Carvalho, E.; Mizuno, C.M.; Coradello, L.F.C.; et al. Evaluating methods for the isolation of marine-derived fungal strains and production of bioactive secondary metabolites. Rev. Bras. Farmacogn. 2012, 22, 257–267. [Google Scholar] [CrossRef] [Green Version]
  121. Gao, H.; Zhang, L.; Zhu, T.; Gu, Q.; Li, D. Unusual pyrrolyl 4-quinolinone alkaloids from the marine-derived fungus Penicillium sp. ghq208. Chem. Pharm. Bull. 2012, 60, 1458–1460. [Google Scholar] [CrossRef] [PubMed]
  122. Myobatake, Y.; Takeuchi, T.; Kuramochi, K.; Kuriyama, I.; Ishido, T.; Hirano, K.; Sugawara, F.; Yoshida, H.; Mizushina, Y. Pinophilins A and B, inhibitors of mammalian A-, B-, and Y-family DNA polymerases and human cancer cell proliferation. J. Nat. Prod. 2012, 75, 135–141. [Google Scholar] [CrossRef] [PubMed]
  123. Kawahara, T.; Takagi, M.; Shin-ya, K. Three new depsipeptides, JBIR-113, JBIR-114 and JBIR-115, isolated from a marine sponge-derived Penicillium sp. fS36. J. Antibiot. 2012, 65, 147–150. [Google Scholar] [CrossRef] [PubMed]
  124. Chen, Z.; Zheng, Z.; Huang, H.; Song, Y.; Zhang, X.; Ma, J.; Wang, B.; Zhang, C.; Ju, J. Penicacids A–C, three new mycophenolic acid derivatives and immunosuppressive activities from the marine-derived fungus Penicillium sp. SOF07. Bioorg. Med. Chem. Lett. 2012, 22, 3332–3335. [Google Scholar] [CrossRef] [PubMed]
  125. Wu, G.; Ma, H.; Zhu, T.; Li, J.; Gu, Q.; Li, D. Penilactones A and B, two novel polyketides from Antarctic deep-sea derived fungus Penicillium crustosum PRB-2. Tetrahedron 2012, 68, 9745–9749. [Google Scholar] [CrossRef]
  126. Shang, Z.; Li, X.; Meng, L.; Li, C.; Gao, S.; Huang, C.; Wang, B. Chemical profile of the secondary metabolites produced by a deepsea sediment-derived fungus Penicillium commune SD-118. Chin. J. Oceanol. Limnol. 2012, 30, 305–314. [Google Scholar] [CrossRef]
  127. Wang, J.; Liu, P.; Wang, Y.; Wang, H.; Li, J.; Zhuang, Y.; Zhu, W. Antimicrobial aromatic polyketides from gorgonian-associated fungus, Penicillium commune 518. Chin. J. Chem. 2012, 30, 1236–1242. [Google Scholar] [CrossRef]
  128. Geiger, M.; Guitton, Y.; Vansteelandt, M.; Kerzaon, I.; Blanchet, E.; Robiou du Pont, T.; Frisvad, J.C.; Hess, P.; Pouchus, Y.F.; Grovel, O. Cytotoxicity and mycotoxin production of shellfish-derived Penicillium spp., a risk for shellfish consumers. Lett. Appl. Microbiol. 2013, 57, 385–392. [Google Scholar] [CrossRef] [PubMed]
  129. Yurchenko, A.N.; Smetanina, O.F.; Kalinovskii, A.I.; Kirichuk, N.N.; Yurchenko, E.A.; Afiyatullov, S.S. Biologically active metabolites of the facultative marine fungus Penicillium citrinum. Chem. Nat. Comp. 2013, 48, 996–998. [Google Scholar] [CrossRef]
  130. Julianti, E.; Lee, J.H.; Liao, L.; Park, W.; Park, S.; Oh, D.C.; Oh, K.B.; Shin, J. New polyaromatic metabolites from a marine-derived fungus Penicillium sp. Org. Lett. 2013, 15, 1286–1289. [Google Scholar] [CrossRef] [PubMed]
  131. Subramani, R.; Kumar, R.; Prasad, P.; Aalbersberg, W. Cytotoxic and antibacterial substances against multi-drug resistant pathogens from marine sponge symbiont: Citrinin, a secondary metabolite of Penicillium sp. Asian Pac. J. Trop. Biomed. 2013, 3, 291–296. [Google Scholar] [CrossRef]
  132. Wang, M.H.; Li, X.M.; Li, C.S.; Ji, N.Y.; Wang, B.G. Secondary metabolites from Penicillium pinophilum SD-272, a marine sediment-derived fungus. Mar. Drugs 2013, 11, 2230–2238. [Google Scholar] [CrossRef] [PubMed]
  133. Flewelling, A.J.; Johnson, J.A.; Gray, C.A. Antimicrobials from the marine algal endophyte Penicillium sp. Nat. Prod. Commun. 2013, 8, 373–374. [Google Scholar] [PubMed]
  134. Qi, J.; Shao, C.L.; Li, Z.Y.; Gan, L.S.; Fu, X.M.; Bian, W.T.; Zhao, H.Y.; Wang, C.Y. Isocoumarin derivatives and benzofurans from a sponge-derived Penicillium sp. fungus. J. Nat. Prod. 2013, 76, 571–579. [Google Scholar] [CrossRef] [PubMed]
  135. He, F.; Han, Z.; Peng, J.; Qian, P.Y.; Qi, S.H. Antifouling indole alkaloids from two marine derived fungi. Nat. Prod. Commun. 2013, 8, 329–332. [Google Scholar] [PubMed]
  136. Bao, J.; Sun, Y.L.; Zhang, X.Y.; Han, Z.; Gao, H.C.; He, F.; Qian, P.Y.; Qi, S.H. Antifouling and antibacterial polyketides from marine gorgonian coral-associated fungus Penicillium sp. SCSGAF 0023. J. Antibiot. 2013, 66, 219–223. [Google Scholar] [CrossRef] [PubMed]
  137. Sohn, J.H.; Lee, D.S.; Oh, H.C. PTP1B inhibitory secondary metabolites from marine-derived fungal strains Penicillium spp. and Eurotium sp. J. Microbiol. Biotechnol. 2013, 23, 1206–1211. [Google Scholar] [CrossRef] [PubMed]
  138. Lee, D.S.; Ko, W.; Quang, T.H.; Kim, K.S.; Sohn, J.H.; Jang, J.H.; Ahn, J.S.; Kim, Y.C.; Oh, H. Penicillinolide A: A new anti-inflammatory metabolite from the marine fungus Penicillium sp. SF-5292. Mar. Drugs 2013, 11, 4510–4526. [Google Scholar] [CrossRef] [PubMed]
  139. Lee, C.; Sohn, J.H.; Jang, J.H.; Ahn, J.S.; Oh, H.; Baltrusaitis, J.; Hwang, I.H.; Gloer, J.B. Cycloexpansamines A and B: Spiroindolinone alkaloids from a marine isolate of Penicillium sp.(SF-5292). J. Antibiot. 2015, 68, 715–718. [Google Scholar] [CrossRef]
  140. Lee, D.S.; Jang, J.H.; Ko, W.; Kim, K.S.; Sohn, J.H.; Kang, M.S.; Ahn, J.S.; Kim, Y.C.; Oh, H. PTP1B inhibitory and anti-inflammatory effects of secondary metabolites isolated from the marine-derived fungus Penicillium sp. JF-55. Mar. Drugs 2013, 11, 1409–1426. [Google Scholar] [CrossRef] [PubMed]
  141. Quang, T.H.; Lee, D.S.; Sohn, J.H.; Kim, Y.C.; Oh, H. A new deoxyisoaustamide derivative from the marine-derived fungus Penicillium sp. JF-72. Bull. Korean Chem. Soc. 2013, 34, 3109–3112. [Google Scholar] [CrossRef]
  142. An, C.Y.; Li, X.M.; Li, C.S.; Gao, S.S.; Shang, Z.; Wang, B.G. Triazoles and other N-containing metabolites from the marine-derived endophytic fungus Penicillium chrysogenum EN-118. Helv. Chim. Acta 2013, 96, 682–687. [Google Scholar] [CrossRef]
  143. Gao, H.; Zhou, L.; Li, D.; Gu, Q.; Zhu, T.J. New cytotoxic metabolites from the marine-derived fungus Penicillium sp. ZLN29. Helv. Chim. Acta 2013, 96, 514–519. [Google Scholar] [CrossRef]
  144. Scopel, M.; Abraham, W.-R.; Henriques, A.T.; MacEdo, A.J. Dipeptide cis-cyclo(Leucyl-Tyrosyl) produced by sponge associated Penicillium sp. F37 inhibits biofilm formation of the pathogenic Staphylococcus epidermidis. Bioorg. Med. Chem. Lett. 2013, 23, 624–626. [Google Scholar] [CrossRef] [PubMed]
  145. Wu, G.; Lin, A.; Gu, Q.; Zhu, T.; Li, D. Four new chloro-eremophilane sesquiterpenes from an Antarctic deep-sea derived fungus, Penicillium sp. PR19N-1. Mar. Drugs 2013, 11, 1399–1408. [Google Scholar] [CrossRef] [PubMed]
  146. Lin, A.; Wu, G.; Gu, Q.; Zhu, T.; Li, D. New eremophilane-type sesquiterpenes from an Antarctic deep-sea derived fungus, Penicillium sp. PR19 N-1. Arch. Pharm. Res. 2014, 37, 839–844. [Google Scholar] [CrossRef] [PubMed]
  147. Sun, Y.L.; Zhang, X.Y.; Zheng, Z.H.; Xu, X.Y.; Qi, S.H. Three new polyketides from marine-derived fungus Penicillium citrinum SCSGAF 0167. Nat. Prod. Res. 2014, 28, 239–244. [Google Scholar] [CrossRef] [PubMed]
  148. An, C.Y.; Li, X.M.; Li, C.S.; Xu, G.M.; Wang, B.G. Prenylated indolediketopiperazine peroxides and related homologues from the marine sediment-derived fungus Penicillium brefeldianum SD-273. Mar. Drugs 2014, 12, 746–756. [Google Scholar] [CrossRef] [PubMed]
  149. He, J.B.; Ji, Y.N.; Hu, D.B.; Zhang, S.; Yan, H.; Liu, X.C.; Luo, H.R.; Zhu, H.J. Structure and absolute configuration of penicilliumine, a new alkaloid from Penicillium commune 366606. Tetrahedron Lett. 2014, 55, 2684–2686. [Google Scholar] [CrossRef]
  150. Li, X.D.; Miao, F.P.; Liang, X.R.; Ji, N.Y. Meroterpenes from an algicolous strain of Penicillium echinulatum. Magn. Res. Chem. 2014, 52, 247–250. [Google Scholar] [CrossRef]
  151. Liao, L.; Lee, J.H.; You, M.; Choi, T.J.; Park, W.; Lee, S.K.; Oh, D.C.; Oh, K.B.; Shin, J. Penicillipyrones A and B, meroterpenoids from a marine-derived Penicillium sp. fungus. J. Nat. Prod. 2014, 77, 406–410. [Google Scholar] [CrossRef] [PubMed]
  152. Kumla, D.; Dethoup, T.; Buttachon, S.; Singburaudom, N.; Silva, A.M.; Kijjoa, A. Spiculisporic acid E, a new spiculisporic acid derivative and ergosterol derivatives from the marine-sponge associated fungus Talaromyces trachyspermus (KUFA 0021). Nat. Prod. Commun. 2014, 9, 1147–1150. [Google Scholar]
  153. Peng, J.; Zhang, X.; Du, L.; Wang, W.; Zhu, T.; Gu, Q.; Li, D. Sorbicatechols A and B, antiviral sorbicillinoids from the marine-derived fungus Penicillium chrysogenum PJX-17. J. Nat. Prod. 2014, 77, 424–428. [Google Scholar] [CrossRef] [PubMed]
  154. Kim, D.C.; Lee, H.S.; Ko, W.; Lee, D.S.; Sohn, J.H.; Yim, J.H.; Kim, Y.C.; Oh, H. Anti-inflammatory effect of methylpenicinoline from a marine isolate of Penicillium sp. (SF-5995): Inhibition of NF-κB and MAPK pathways in lipopolysaccharide-induced RAW264.7 macrophages and BV2 microglia. Molecules 2014, 19, 18073–18089. [Google Scholar] [CrossRef] [PubMed]
  155. Liu, Y.; Li, X.M.; Meng, L.H.; Jiang, W.L.; Xu, G.M.; Huang, C.G.; Wang, B.G. Bisthiodiketopiperazines and acorane sesquiterpenes produced by the marine-derived fungus Penicillium adametzioides AS-53 on different culture media. J. Nat. Prod. 2015, 78, 1294–1299. [Google Scholar] [CrossRef] [PubMed]
  156. Liu, Y.; Mándi, A.; Li, X.M.; Meng, L.H.; Kurtán, T.; Wang, B.G. Peniciadametizine A, a dithiodiketopiperazine with a unique spiro [furan-2,7′-pyrazino[1,2-b][1,2]oxazine] skeleton, and a related analogue, peniciadametizine B, from the marine sponge-derived fungus Penicillium adametzioides. Mar. Drugs 2015, 13, 3640–3652. [Google Scholar] [CrossRef] [PubMed]
  157. Liu, Y.; Li, X.M.; Meng, L.H.; Wang, B.G. N-Formyllapatin A, a new N-formylspiroquinazoline derivative from the marine-derived fungus Penicillium adametzioides AS-53. Phytochem. Lett. 2014, 10, 145–148. [Google Scholar] [CrossRef]
  158. Quang, T.H.; Ngan, N.T.T.; Ko, W.; Kim, D.C.; Yoon, C.S.; Sohn, J.H.; Yim, J.H.; Kim, Y.C.; Oh, H. Tanzawaic acid derivatives from a marine isolate of Penicillium sp. (SF-6013) with anti-inflammatory and PTP1B inhibitory activities. Bioorg. Med. Chem. Lett. 2014, 24, 5787–5791. [Google Scholar] [CrossRef] [PubMed]
  159. Kildgaard, S.; Mansson, M.; Dosen, I.; Klitgaard, A.; Frisvad, J.C.; Larsen, T.O.; Nielsen, K.F. Accurate dereplication of bioactive secondary metabolites from marine-derived fungi by UHPLC-DAD-QTOFMS and a MS/HRMS library. Mar. Drugs 2014, 12, 3681–3705. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  160. Zhuravleva, O.I.; Sobolevskaya, M.P.; Afiyatullov, S.S.; Kirichuk, N.N.; Denisenko, V.A.; Dmitrenok, P.S.; Yurchenko, E.A.; Dyshlovoy, S.A. Sargassopenillines A–G, 6,6-spiroketals from the alga-derived fungi Penicillium thomii and Penicillium lividum. Mar. Drugs 2014, 12, 5930–5943. [Google Scholar] [CrossRef] [PubMed]
  161. Wu, B.; Ohlendorf, B.; Oesker, V.; Wiese, J.; Malien, S.; Schmaljohann, R.; Imhoff, J.F. Acetylcholinesterase inhibitors from a marine fungus Talaromyces sp. strain LF458. Mar. Biotechnol. 2015, 17, 110–119. [Google Scholar] [CrossRef] [PubMed]
  162. Chen, M.; Han, L.; Shao, C.L.; She, Z.G.; Wang, C.Y. Bioactive diphenyl ether derivatives from a gorgonian-derived fungus Talaromyces sp. Chem. Biodivers. 2015, 12, 443–450. [Google Scholar] [CrossRef] [PubMed]
  163. Zhao, D.L.; Shao, C.L.; Zhang, Q.; Wang, K.L.; Guan, F.F.; Shi, T.; Wang, C.Y. Azaphilone and diphenyl ether derivatives from a gorgonian-derived strain of the fungus Penicillium pinophilum. J. Nat. Prod. 2015, 78, 2310–2314. [Google Scholar] [CrossRef] [PubMed]
  164. Ngokpol, S.; Suwakulsiri, W.; Sureram, S.; Lirdprapamongkol, K.; Aree, T.; Wiyakrutta, S.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Drimane sesquiterpene-conjugated amino acids from a marine isolate of the fungus Talaromyces minioluteus (Penicillium minioluteum). Mar. Drugs 2015, 13, 3567–3580. [Google Scholar] [CrossRef] [PubMed]
  165. Afiyatullov, S.S.; Leshchenko, E.V.; Sobolevskaya, M.P.; Gerasimenko, A.V.; Khudyakova, Y.V.; Kirichuk, N.N.; Mikhailov, V.V. New 3-[2′(R)-hydroxybutyl]-7-hydroxyphthalide from marine isolate of the fungus Penicillium claviforme. Chem. Nat. Comp. 2015, 51, 111–115. [Google Scholar] [CrossRef]
  166. Asiri, I.A.; Badr, J.M.; Youssef, D.T. Penicillivinacine, antimigratory diketopiperazine alkaloid from the marine-derived fungus Penicillium vinaceum. Phytochem. Lett. 2015, 13, 53–58. [Google Scholar] [CrossRef]
  167. Shaala, L.A.; Youssef, D.T. Identification and bioactivity of compounds from the fungus Penicillium sp. CYE-87 isolated from a marine tunicate. Mar. Drugs 2015, 13, 1698–1709. [Google Scholar] [CrossRef] [PubMed]
  168. Fan, Y.-Q.; Li, P.-H.; Chao, Y.-X.; Chen, H.; Du, N.; He, Q.-X.; Liu, K.-C. Alkaloids with cardiovascular effects from the marine-derived fungus Penicillium expansum Y32. Mar. Drugs 2015, 13, 6489–6504. [Google Scholar] [CrossRef] [PubMed]
  169. Kim, J.W.; Ko, S.K.; Son, S.; Shin, K.S.; Ryoo, I.J.; Hong, Y.S.; Oh, H.; Hwang, B.Y.; Hirota, H.; Takahashi, S.; et al. Haenamindole, an unusual diketopiperazine derivative from a marine-derived Penicillium sp. KCB12F005. Bioorg. Med. Chem. Lett. 2015, 25, 5398–5401. [Google Scholar] [CrossRef] [PubMed]
  170. Cardoso-Martínez, F.; de la Rosa, J.M.; Díaz-Marrero, A.R.; Darias, J.; Cerella, C.; Diederich, M.; Cueto, M. Tanzawaic acids isolated from a marine-derived fungus of the genus Penicillium with cytotoxic activities. Org. Biomol. Chem. 2015, 13, 7248–7256. [Google Scholar] [CrossRef] [PubMed]
  171. Bu, Y.Y.; Yamazaki, H.; Takahashi, O.; Kirikoshi, R.; Ukai, K.; Namikoshi, M. Penicyrones A and B, an epimeric pair of α-pyrone-type polyketides produced by the marine-derived Penicillium sp. J. Antibiot. 2016, 69, 57–61. [Google Scholar] [CrossRef]
  172. Ding, Z.; Zhang, L.; Fu, J.; Che, Q.; Li, D.; Gu, Q.; Zhu, T. Phenylpyropenes E and F: New meroterpenes from the marine-derived fungus Penicillium concentricum ZLQ-69. J. Antibiot. 2015, 68, 748–751. [Google Scholar] [CrossRef] [PubMed]
  173. Yamazaki, H.; Nakayama, W.; Takahashi, O.; Kirikoshi, R.; Izumikawa, Y.; Iwasaki, K.; Toraiwa, K.; Ukai, K.; Rotinsulu, H.; Wewengkang, D.S.; et al. Verruculides A and B, two new protein tyrosine phosphatase 1B inhibitors from an Indonesian ascidian-derived Penicillium verruculosum. Bioorg. Med. Chem. Lett. 2015, 25, 3087–3090. [Google Scholar] [CrossRef] [PubMed]
  174. Lynn, D.G.; Phillips, N.J.; Hutton, W.C.; Shabanowitz, J.; Fennell, D.I.; Cole, R.J. Talaromycins: Application of homonuclear spin correlation maps to structure assignment. J. Am. Chem. Soc. 1982, 104, 7319–7322. [Google Scholar] [CrossRef]
  175. Frisvad, J.C.; Filtenborg, O.; Samson, R.A.; Stolk, A.C. Chemotaxonomy of the genus Talaromyces. Antonie Van Leeuwenhoek 1990, 57, 179–189. [Google Scholar] [CrossRef] [PubMed]
  176. Gao, Z.; Li, B.; Zheng, C.; Wang, G. Molecular detection of fungal communities in the Hawaiian marine sponges Suberites zeteki and Mycale armata. Appl. Environ. Microbiol. 2008, 74, 6091–6101. [Google Scholar] [CrossRef] [PubMed]
  177. Webster, N.S.; Taylor, M.W. Marine sponges and their microbial symbionts: Love and other relationships. Environ. Microbiol. 2012, 14, 335–346. [Google Scholar] [CrossRef] [PubMed]
  178. Gosio, B. Ricerche bacteriologiche e chimiche sulle alterazioni del mais. Riv. Ig. Sanità Pubblica 1896, 7, 825–868. [Google Scholar]
  179. Clutterbuck, P.W.; Raistrick, H. Studies in the biochemistry of microorganisms XXXI. The molecular constitution of the metabolic products of Penicillium brevi-compactum Dierckx and related species. Biochem. J. 1933, 27, 654–667. [Google Scholar] [CrossRef] [PubMed]
  180. Lipsky, J.L. Mycophenolate mofetil. Lancet 1996, 348, 1357–1359. [Google Scholar] [CrossRef]
  181. Bentley, R. Mycophenolic acid: A one hundred year odyssey from antibiotic to immunosuppressant. Chem. Rev. 2000, 100, 3801–3826. [Google Scholar] [CrossRef] [PubMed]
  182. Oxford, A.E.; Raistrick, H.; Simonart, P. Studies in the biochemistry of microorganisms. LX. Griseofulvin, C17H17O6Cl, a metabolic product of Penicillium griseo-fulvum Dierckx. Biochem. J. 1939, 33, 240–248. [Google Scholar] [CrossRef] [PubMed]
  183. Nicoletti, R.; Fiorentino, A. Antitumor metabolites of fungi. Curr. Bioact. Compd. 2014, 10, 207–244. [Google Scholar] [CrossRef]
  184. Johnson, J.R.; Bruce, W.F.; Dutcher, J.D. Gliotoxin, the antibiotic principle of Gliocladium fimbriatum. I. Production, physical and biological properties. J. Am. Chem. Soc. 1943, 65, 2005–2009. [Google Scholar] [CrossRef]
  185. Sekita, S.; Yoshihira, K.; Natori, S.; Kuwano, H. Structures of chaetoglobosin A and B, cytotoxic metabolites of Chaetomium globosum. Tetrahedron Lett. 1973, 14, 2109–2112. [Google Scholar] [CrossRef]
  186. De Stefano, S.; Nicoletti, R.; Milone, A.; Zambardino, S. 3-O-Methylfunicone, a fungitoxic metabolite produced by the fungus Penicillium pinophilum. Phytochemistry 1999, 52, 1399–1401. [Google Scholar] [CrossRef]
  187. Nicoletti, R.; de Stefano, M.; de Stefano, S.; Trincone, A.; Marziano, F. Antagonism against Rhizoctonia solani and fungitoxic metabolite production by some Penicillium isolates. Mycopathologia 2004, 158, 465–474. [Google Scholar] [CrossRef] [PubMed]
  188. Stammati, A.; Nicoletti, R.; De Stefano, S.; Zampaglioni, F.; Zucco, F. Cytostatic properties of a novel compound derived from Penicillium pinophilum: An in vitro study. Altern. Lab. Anim. 2002, 30, 1–7. [Google Scholar]
  189. Buommino, E.; Nicoletti, R.; Gaeta, G.M.; Orlando, M.; Ciavatta, M.L.; Baroni, A.; Tufano, M.A. 3-O-Methylfunicone induces apoptosis and hsp70 activation in HeLa cells. Cell Prolif. 2004, 37, 413–426. [Google Scholar] [CrossRef] [PubMed]
  190. Buommino, E.; Boccellino, M.; De Filippis, A.; Petrazzuolo, M.; Cozza, V.; Nicoletti, R.; Ciavatta, M.L.; Quagliuolo, L.; Tufano, M.A. 3-O-methylfunicone produced by Penicillium pinophilum affects cell motility of breast cancer cells, downregulating αvβ5 integrin and inhibiting metalloproteinase-9 secretion. Mol. Carcinog. 2007, 46, 930–940. [Google Scholar] [CrossRef]
  191. Nicoletti, R.; Buommino, E.; De Filippis, A.; Lopez-Gresa, M.P.; Manzo, E.; Carella, A.; Petrazzuolo, M.; Tufano, M.A. Bioprospecting for antagonistic Penicillium strains as a resource of new antitumor compounds. World J. Microbiol. Biotechnol. 2008, 24, 189–195. [Google Scholar] [CrossRef]
  192. Baroni, A.; De Luca, A.; De Filippis, A.; Petrazzuolo, M.; Manente, L.; Nicoletti, R.; Tufano, M.A.; Buommino, E. 3-O-Methylfunicone, a metabolite from Penicillium pinophilum, inhibits proliferation of human melanoma cells by causing G2/M arrest and inducing apoptosis. Cell Prolif. 2009, 42, 541–553. [Google Scholar] [CrossRef] [PubMed]
  193. Nicoletti, R.; Manzo, E.; Ciavatta, M.L. Occurence and bioactivities of funicone-related compounds. Int. J. Mol. Sci. 2009, 10, 1430–1444. [Google Scholar] [CrossRef] [PubMed]
  194. Buommino, E.; Paoletti, I.; De Filippis, A.; Nicoletti, R.; Ciavatta, M.L.; Menegozzo, S.; Menegozzo, M.; Tufano, M.A. 3-O-Methylfunicone, a metabolite produced by Penicillium pinophilum, modulates ERK1/2 activity, affecting cell motility of human mesothelioma cells. Cell Prolif. 2010, 43, 114–123. [Google Scholar] [CrossRef] [PubMed]
  195. Buommino, E.; Tirino, V.; De Filippis, A.; Silvestri, F.; Nicoletti, R.; Ciavatta, M.L.; Pirozzi, G.; Tufano, M.A. 3-O-methylfunicone, from Penicillium pinophilum, is a selective inhibitor of breast cancer stem cells. Cell Prolif. 2011, 44, 401–409. [Google Scholar] [CrossRef] [PubMed]
  196. Buommino, E.; De Filippis, A.; Nicoletti, R.; Menegozzo, M.; Menegozzo, S.; Ciavatta, M.L.; Rizzo, A.; Brancato, V.; Tufano, M.A.; Donnarumma, G. Cell-growth and migration inhibition of human mesothelioma cells induced by 3-O-methylfunicone from Penicillium pinophilum and cisplatin. Investig. New Drugs 2012, 30, 1343–1351. [Google Scholar] [CrossRef] [PubMed]
  197. Nicoletti, R.; Scognamiglio, M.; Fiorentino, A. Structural and bioactive properties of 3-O-methylfunicone. Mini Rev. Med. Chem. 2014, 14, 1043–1047. [Google Scholar] [CrossRef]
  198. Harned, A.M.; Volp, K.A. The sorbicillinoid family of natural products: Isolation, biosynthesis, and synthetic studies. Nat. Prod. Rep. 2011, 28, 1790–1810. [Google Scholar] [CrossRef] [PubMed]
  199. Cram, D.J. Mold metabolites. II. The structure of sorbicillin, a pigment produced by the mold Penicillium notatum. J. Am. Chem. Soc. 1948, 70, 4240–4243. [Google Scholar] [CrossRef] [PubMed]
  200. Visagie, C.M.; Houbraken, J.; Frisvad, J.C.; Hong, S.B.; Klaassen, C.H.W.; Perrone, G.; Seifert, K.A.; Varga, J.; Yaguchi, T.; Samson, R.A. Identification and nomenclature of the genus Penicillium. Stud. Mycol. 2014, 78, 343–371. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  201. Matallah-Boutiba, A.; Ruiz, N.; Sallenave-Namont, C.; Grovel, O.; Amiard, J.C.; Pouchus, Y.F.; Boutiba, Z. Screening for toxigenic marine-derived fungi in Algerian mussels and their immediate environment. Aquaculture 2012, 342, 75–79. [Google Scholar] [CrossRef]
  202. Greve, H.; Mohamed, I.E.; Pontius, A.; Kehraus, S.; Gross, H.; König, G.M. Fungal metabolites: Structural diversity as incentive for anticancer drug development. Phytochem. Rev. 2010, 9, 537–545. [Google Scholar] [CrossRef]
  203. Gomes, N.G.; Lefranc, F.; Kijjoa, A.; Kiss, R. Can some marine-derived fungal metabolites become actual anticancer agents? Mar. Drugs 2015, 13, 3950–3991. [Google Scholar] [CrossRef] [PubMed]
  204. Kakeya, H.; Onozawa, C.; Sato, M.; Arai, K.; Osada, H. Neuritogenic effect of epolactaene derivatives on human neuroblastoma cells which lack high-affinity nerve growth factor receptors. J. Med. Chem. 1997, 40, 391–394. [Google Scholar] [CrossRef] [PubMed]
  205. Perpelescu, M.; Kobayashi, J.I.; Furuta, M.; Ito, Y.; Izuta, S.; Takemura, M.; Suzuki, M.; Yoshida, S. Novel phenalenone derivatives from a marine-derived fungus exhibit distinct inhibition spectra against eukaryotic DNA polymerases. Biochemistry 2002, 41, 7610–7616. [Google Scholar] [CrossRef] [PubMed]
  206. Mizushina, Y.; Kobayashi, S.; Kuramochi, K.; Nagata, S.; Sugawara, F.; Sakaguchi, K. Epolactaene, a novel neuritogenic compound in human neuroblastoma cells, selectively inhibits the activities of mammalian DNA polymerases and human DNA topoisomerase II. Biochem. Biophys. Res. Commun. 2000, 273, 784–788. [Google Scholar] [CrossRef] [PubMed]
  207. Nitiss, J.L. Targeting DNA topoisomerase II in cancer chemotherapy. Nat. Rev. Cancer 2009, 9, 338–350. [Google Scholar] [CrossRef] [PubMed]
  208. Yamaguchi, K.; Tsuji, T.; Wakuri, S.; Yazawa, K.; Kondo, K.; Shigemori, H.; Kobayashi, J.I. Stimulation of nerve growth factor synthesis and secretion by fellutamide A in vitro. Biosci. Biotechnol. Biochem. 1993, 57, 195–199. [Google Scholar] [CrossRef] [PubMed]
  209. Hines, J.; Groll, M.; Fahnestock, M.; Crews, C.M. Proteasome inhibition by fellutamide B induces nerve growth factor synthesis. Chem. Biol. 2008, 15, 501–512. [Google Scholar] [CrossRef] [PubMed]
  210. Yang, X.; Du, L.; Tang, X.; Jung, S.Y.; Zheng, B.; Soh, B.Y.; Kim, S.Y.; Gu, Q.; Park, H. Brevicompanine E reduces lipopolysaccharide-induced production of proinflammatory cytokines and enzymes in microglia by inhibiting activation of activator protein-1 and nuclear factor-κB. J. Neuroimmunol. 2009, 216, 32–38. [Google Scholar] [CrossRef] [PubMed]
  211. Chen, Y.P.; Yang, C.G.; Wei, P.Y.; Li, L.; Luo, D.Q.; Zheng, Z.H.; Lu, X.H. Penostatin derivatives, a novel kind of protein phosphatase 1B inhibitors isolated from solid cultures of the entomogenous fungus Isaria tenuipes. Molecules 2014, 19, 1663–1671. [Google Scholar] [CrossRef] [PubMed]
  212. Murray, A.P.; Faraoni, M.B.; Castro, M.J.; Alza, N.P.; Cavallaro, V. Natural AChE inhibitors from plants and their contribution to Alzheimer’s disease therapy. Curr. Neuropharmacol. 2013, 11, 388–413. [Google Scholar] [CrossRef] [PubMed]
  213. Lin, G.; Li, D.; Chidawanyika, T.; Nathan, C.; Li, H. Fellutamide B is a potent inhibitor of the Mycobacterium tuberculosis proteasome. Arch. Biochem. Biophys. 2010, 501, 214–220. [Google Scholar] [CrossRef] [PubMed]
  214. Zhao, J.C.; Li, X.M.; Gloer, J.B.; Wang, B.G. First total syntheses and antimicrobial evaluation of penicimonoterpene, a marine-derived monoterpenoid, and its various derivatives. Mar. Drugs 2014, 12, 3352–3370. [Google Scholar] [CrossRef] [PubMed]
  215. Hayashi, H.; Matsumoto, H.; Akiyama, K. New insecticidal compounds, communesins C, D and E, from Penicillium expansum Link MK-57. Biosci. Biotechnol. Biochem. 2004, 68, 753–756. [Google Scholar] [CrossRef] [PubMed]
  216. Park, M.S.; Fong, J.J.; Oh, S.Y.; Kwon, K.K.; Sohn, J.H.; Lim, Y.W. Marine-derived Penicillium in Korea: Diversity, enzyme activity, and antifungal properties. Antonie Van Leeuwenhoek 2014, 106, 331–345. [Google Scholar] [CrossRef] [PubMed]
  217. Bringmann, G.; Gulder, T.A.; Lang, G.; Schmitt, S.; Stöhr, R.; Wiese, J.; Nagel, K.; Imhoff, J.F. Large-scale biotechnological production of the antileukemic marine natural product sorbicillactone A. Mar. Drugs 2007, 5, 23–30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Marinedrugs 14 00037 g001a 1024Marinedrugs 14 00037 g001b 1024Marinedrugs 14 00037 g001c 1024Marinedrugs 14 00037 g001d 1024
Figure 1. Structures of novel compounds produced by marine Penicillium/Talaromyces strains displaying inhibitory properties against mammalian tumor cell lines. For the sake of space, compounds produced in series of two or more analogs are presented as a single or type structure.
Figure 1. Structures of novel compounds produced by marine Penicillium/Talaromyces strains displaying inhibitory properties against mammalian tumor cell lines. For the sake of space, compounds produced in series of two or more analogs are presented as a single or type structure.
Marinedrugs 14 00037 g001aMarinedrugs 14 00037 g001bMarinedrugs 14 00037 g001cMarinedrugs 14 00037 g001d
Marinedrugs 14 00037 g002 1024
Figure 2. Structures of novel compounds produced by marine Penicillium/Talaromyces strains displaying anti-inflammatory effects.
Figure 2. Structures of novel compounds produced by marine Penicillium/Talaromyces strains displaying anti-inflammatory effects.
Marinedrugs 14 00037 g002
Marinedrugs 14 00037 g003 1024
Figure 3. Structures of novel compounds produced by marine Penicillium/Talaromyces strains reported for ROS-scavenging properties.
Figure 3. Structures of novel compounds produced by marine Penicillium/Talaromyces strains reported for ROS-scavenging properties.
Marinedrugs 14 00037 g003
Marinedrugs 14 00037 g004 1024
Figure 4. Structures of novel compounds produced by marine Penicillium/Talaromyces strains with enzyme-modulatory activities.
Figure 4. Structures of novel compounds produced by marine Penicillium/Talaromyces strains with enzyme-modulatory activities.
Marinedrugs 14 00037 g004
Marinedrugs 14 00037 g005 1024
Figure 5. Structures of novel antibiotic compounds produced by marine Penicillium/Talaromyces strains.
Figure 5. Structures of novel antibiotic compounds produced by marine Penicillium/Talaromyces strains.
Marinedrugs 14 00037 g005
Marinedrugs 14 00037 g006 1024
Figure 6. Structure of cis-cyclo(leucyl-tyrosyl) dipeptide.
Figure 6. Structure of cis-cyclo(leucyl-tyrosyl) dipeptide.
Marinedrugs 14 00037 g006
Marinedrugs 14 00037 g007 1024
Figure 7. Structures of sorbicathecols.
Figure 7. Structures of sorbicathecols.
Marinedrugs 14 00037 g007
Marinedrugs 14 00037 g008 1024
Figure 8. Structures of novel compounds produced by marine Penicillium/Talaromyces characterized for miscellaneous bioactive effects.
Figure 8. Structures of novel compounds produced by marine Penicillium/Talaromyces characterized for miscellaneous bioactive effects.
Marinedrugs 14 00037 g008
Table
Table 1. Secondary metabolites of Penicillium and Talaromyces strains of marine origin. List is based on the chronological order of isolation of the producing strains.
Table 1. Secondary metabolites of Penicillium and Talaromyces strains of marine origin. List is based on the chronological order of isolation of the producing strains.
Species Name 1Strain No.Source of Isolation 2LocationProducts 3References
P. fellutanum
(P. dierckxii)		-F Apogon endekataeniaManazaru (Japan)Fellutamide A–B[28]
Penicillium sp.
(P. marinum)		OUPS-79G Ulva (Enteromorpha) intestinalisTanabe Bay (Japan)Communesin A–B, Penochalasin A–H, Penostatin A–I,
Chaetoglobosin A,F,O, Patulin, Epiepoxydon		[29,30,31,32,33,34]
P. citrinum-S unidentified spongeSuruga Bay (Japan)Cathestatin A–B, Estatin A–B[35]
Penicillium sp.BM1689-PsedimentUchiura Bay (Japan)Epolactaene[36]
Penicillium sp.BM923sedimentMiho (Japan)Acetophthalidin, 3,4,6-Trihydroxymellein[37]
Penicillium sp.-intertidal sedimentSan Antonio Oeste (Argentina)Cyclo(l-prolyl-l-tyrosyl)[38]
Penicillium sp.NI15501sediment (depth 14 m)Tomari (Japan)NI15501A[39]
P. waksmaniiOUPS-N133B Sargassum ringgoldianumJapanPyrenocine A–B,D–E, Cis-bis(methylthio)silvatin[40]
P. citrinummany strainsseveral sourcesMochima Bay and Paria Bay (Venezuela)Citrinin, Tanzawaic acid A[41,42]
P. steckiiM23B-7 = IBT20952 and 12 more strainsT unidentified tunicate, and other sources (molluscs, fish, sponges)Mochima Bay and Paria Bay (Venezuela)Tanzawaic acid E–F, 3,7-Dimethyl-8-hydroxy-6-methoxyisochroman, 3,7-Dimethyl-1,8-dihydroxy-6-methoxyisochroman[41,42]
Penicillium sp.#CNC-350G Avrainvillea longicaulisSweetings Cay (Bahamas)Verticillin A, 11′-Deoxyverticillin A, 11,11′-Dideoxyverticillin A, Bisdethio-bis(methylthio)-dioxopiperazine[43]
Penicillium sp.K029M Mytilus coruscusSeragaki (Japan)Coruscol A, Herquline A[44]
Penicillium sp.K036M M. coruscusSeragaki (Japan)Sculezonone A–B[45]
Penicillium sp.#386sandSouth China SeaPenicillazine (Trichodermamide A)[46]
P. cf. montanenseHBI-3/DS Xestospongia exiguaMangangan Island (Indonesia)Xestodecalactone A–C[47]
P. citrinum991084S Axinella sp.Papua New GuineaIsocyclocitrinol A, 22-Acetylisocyclocitrinol A[48]
P. brocaeF97S76S Zyzzya sp.FijiBrocaenol A–C[49]
Penicillium sp.
(P. dravuni)		F01V25G Dictyosphaeria versluyiiDravuni (Fiji)Dictyosphaeric acid A–B, Carviolin[50]
Penicillium sp.
(P. marinum)		E-00-12/3S Axinella verrucosaElba Island (Italy)Communesin B,C–D, Griseofulvin, Dechlorogriseofulvin, Oxaline[51]
P. cf. brevicompactumE-00-2/6aS Petrosia ficiformisElba Island (Italy)Petrosifungin A–B, Brevianamide A, Asperphenamate, Mycophenolic acid[52]
Penicillium sp.a004181, b004181sediment (depth 4380 ft)Matuka (Fiji)Anserinone A–B, Formylanserinone B, Epoxyserinone A–B, Deoxyanserinone B, Hydroxymethylanserinone B[53]
P. waksmanii (Penicillium sp.)LCP99.43.43 = MMS351waterLa Prée (France)Griseofulvin, Dechlorogriseofulvin, Orcinol, Penicillic acid, Agroclavine, Festuclavine, Nortryptoquivaline, Ligerin[54,55,56]
P. citrinumN059R Actinotrichia fragilisOkinawa (Japan)Citrinin, Citrinadin A–B[57,58]
P. citrinumN055F Scarus ovifronsOkinawa (Japan)Perinadine A, Scalusamide A–C[59,60]
P. janczewskiiH-TW5/869waterHelgoland Island (Germany)3,4-Dihydroxy-4-(4′-methoxyphenyl)-3,4-dihydro-2(1H)-quinolinone, Peniprequinolone, 3-Methoxy-4-hydroxy-4-(4′-methoxyphenyl)-3,4-dihydro-2(1H)-quinolinone[61]
P. chrysogenumDSM16137 = E01-10/3S Ircinia fasciculataElba Island (Italy)Sorbicillactone A–B, Sorbivinetone, Sorbivinetol, Sorbifuranone A–C, Bisvertinolone, Sorbicillin, Oxosorbicillinol, Meleagrin, Roquefortine C–D[62,63]
P. terrestre
(P. crustosum)		M204077sedimentJiaozhou Bay (China)Sorbicillin, Dihydrobisvertinolone, Tetrahydrobisvertinolone, Trichodimerol, Dihydrotrichodimerol, Tetrahydrotrichodimerol, Sorbiterrin A, Penicillone A–B, Chloctanspirone A–B, Terrestrol A–H,K–L, 2-(2′-3′-Dihydrosorbyl)-3,6-dimethyl-5-hydroxy-1,4-benzoquinone, 3-Acetonyl-2,6-dimethyl-5-hydroxy-1,4-benzoquinone[64,65,66,67,68,69]
P. janthinellum-C Dendronephyta sp.Hainan (China)Griseofulvin, Dechlorogriseofulvin, Janthinolide A–B, Deoxymycelianamide[70]
P. brevicompactumCl-2002S Cliona sp.Quintay (Chile)Mycophenolic acid, Mycophenolic acid methyl ester, Tyrosol[71]
P. rugulosum
(T. rugulosus)		KF021S Chondrosia reniformisElba Island (Italy)Prugosene A1,A2,B1,B2,B3,C1,C2[72]
Penicillium sp.-B Sargassum tortileToyama Bay (Japan)4-Hydroxy-2-methoxyacetanilide, 4-Methoxyphenylacetic acid, 4-(2-Hydroxyethyl)phenol, 3-Methoxyphenol, 4-Hydroxyphenylacetic acid[73]
P. janthinellum-sediment (depth 11 m)Amursky Bay (Sea of Japan)Shearinine A,D–F[74]
P. bilaiaeMST-MF667boat rampPort Huon (Tasmania, Australia)Cyclo(l-prolyl-l-tyrosyl), Cyclo(l-phenalanyl-l-prolyl), Cyclo(l-prolyl-l-valyl), Cis-bis(methylthio)silvatin, Bilain A–C, Pistillarin, Citromycin, 2,3-Dihydrocitromycin, Citromycetin, 2,3-Dihydrocitromycetin[75]
Penicillium sp.MFA446G Ulva pertusaBijin Island (Korea)Citrinin, Citrinin H2, Redoxcitrinin, Phenol A, Phenol A acid, 4-Hydroxymellein[76]
P. aurantiogriseumSP0-19S Mycale plumoseJiaozhou Bay (China)Aurantiomide A–C, Anacin[77]
P. stoloniferum
(P. brevicompactum)		QY2-10T unidentified ascidianJiaozhou Bay (China)Stoloniferol A–B[78]
P. flavidorsum
(P. glabrum)		SHK1-27sedimentWeizhou Island (China)Averufin, 8-O-Methylaverufin, 6,8-O-Dimethylaverufin, Averantin, Nidurufin, Versicolorin A–B, Versiconol[79]
P. minioluteum
(T. minioluteus)		03HE3-1mudHeita Bay (Japan)Miniolutelide A–B, 22-Epoxyberkeleydione[80]
Penicillium sp.BL27-2mudBering Sea3-Acetyl-13-deoxyphomenone, 8α-Hydroxy-13-deoxyphomenone, Sporogen-AO1, 3-Acetyl-9,7(11)-dien-7α-hydroxy-8-oxoeremophilane, 6-Dehydropetasol, 7-Hydroxypetasol[81]
Penicillium sp.SS080624SCf1T Didemnum molleIshigaki Island (Japan)Phomenone, Sporogen-AO1, JBIR-27, JBIR-28[82]
Penicillium sp. (Talaromyces sp.)AF1-2salt panAustralia3-O-Methylfunicone[83]
Penicillium sp.CANU MCPT14-1-5B Xiphophora gladiataOtago (New Zealand)PF1140, Deoxy-PF1140, Deoxyakanthomycin[84]
Penicillium sp.i-1-1G Blidingia minimaYantai (China)Citrinin, Citrinal A, 2,3,4-Trimethyl-5,7-dihydroxy-2,3-dihydrobenzofuran[85]
Penicillium sp.EG-51G Ulva sp.Suez Canal (Egypt)Chromanone A[86]
Penicillium sp.F1sediment (depth 5080 m)Pacific OceanBrevicompanine B,D–H, Fructigenine B[87]
Penicillium sp.F23-2sediment (depth 5080 m)Pacific OceanMeleagrin B–E, Roquefortines F–I, Conidiogenone B–G, Sorbicillamine A–E, Bisvertinolone, Rezishanone C, Penicyclone A–E[88,89,90,91]
Penicillium sp.3A00005sediment (depth 5115 m)East Pacific OceanBrevione A–B,F–K, Sterolic acid[92,93]
P. expansumMMS42sedimentLe Croisic (France)Communesin A–B, D–F, Com470, Com512, Com522, Com524, Com570, Com622, Com 644, Patulin, Chaetoglobosin 528, Chaetoglobosin 530, Citrinin, Roquefortine C–D, Expansolide A–B, Aurantioclavine, Verruculotoxin[54,94]
Penicillium sp.PSU-F44C Annella sp.Similan Islands (Thailand)Penicipyrone, Penicilactone, Brefeldin A,C, Oxobrefeldin A[95]
Penicillium sp.PSU-F40C Annella sp.Similan Islands (Thailand)Penicipyrone, Penicipyranone, Penicisochroman A–E, Penicisoquinoline, Peniciphenol, TMC-120B, TMC-120C, 2-(2-Methoxybenzoyl)pyrrole, 1-(2,4-Dihydroxy-6-methylphenyl)-3-methyl-1-butanone, Nicotinic acid[96]
Penicillium sp.M207142sedimentChina(2E,4E)-1-(2,6-Dihydroxy-3,5-dimethyl-phenyl)hexa-2,4-dien-1-one, Penicillone A, 2′,3′-Dihydrosorbicillin[97]
P. chrysogenumR03-8/4 = LF066S Tethya aurantiumLimsky Canal (Croatia)Meleagrin, Roquefortine C–D, Sorbifuranone B–C, Bisvertinolone, 2′,3′-Dihydrosorbicillin, Xanthocillins, Cillifuranone[63,98]
P. citrinumSpI080624G1f01S unidentified DemospongiaIshigaki Island (Japan)Redoxcitrinin, Sclerotinin A–B, Bisorbibutenolide, Bisvertinolone, Trichodimerol, JBIR-59, JBIR-124[99,100]
P. oxalicumF30 = CBMAI1185G Caulerpa sp.Sao Paulo State (Brazil)Meleagrin, Oxaline[101]
P. citrinumF53 = CBMAI1186G Caulerpa sp.Sao Paulo State (Brazil)Citrinin, Citrinalin A–B, (E)-1-(2,3-dihydro-1H-pyrrol-1-yl)-2-methyldec-8-ene-1,3-dione, 1-(2,3-dihydro-1H-pyrrol-1-yl)-2-methyldecane-1,3-dione[101]
P. griseofulvum-sediment (depth 2481 m)Pacific OceanEchinulin, Preechinulin, Didehydroechinulin, Isoechinulin B, Neoechinulins A–B, Tardioxopiperazine A, Variecolorin H,M–O[102]
P. aurantiogriseumMF361mudBohai Sea (China)Verrucosidin, Norverrrucosidin, Verrucosidinol, Verrucosidinol acetate, Terrestric acid, Aurantiomide C, Auranthine, Auranomide A–C[103,104]
P. chrysogenumMFB574-2R Hypnea species complexYokgee Island (Korea)4,6,4′,6′-Tetrabromo-3,3′-dihydroxy-5,5′-dimethyldiphenyl ether, 4,6,2′,4′,6′-Pentabromo-3,3′-dihydroxy-5,5′-dimethyldiphenyl ether, 3,3′-Dihydroxy-5,5′-dimethyldiphenyl ether, Violacerol I–II[105]
Penicillium sp.CNL-338R Laurencia sp.BahamasPenilumamide, Aspochalasin D–E[106]
P. chrysogenumQEN-24SR Laurencia sp.Weizhou Island (China)Penicitide A–B, Penicimonoterpene, Penicisteroid A–B, Conidiogenol, 2-(2,4-Dihydroxy-6-methylbenzoyl)-glycerol, Anicequol, 1-(2,4-Dihydroxy-6-methylbenzoyl)-glycerol, Conidiogenone B–D,F,H–I[107,108,109]
P. glabrum-P Zostera marina (stem)Trinity Bay (Sea of Japan)Sulochrin, 4-Methoxy-3-methylgoniothalamin[110]
P. implicatum-P Z. marina (rhizome)Trinity Bay (Sea of Japan)Sulochrin, 4-Methoxy-3-methylgoniothalamin[110]
P. citrinum-sedimentLangqi Island (China)Citrinin, Decarboxydihydrocitrinone, Penicitrinol C–E, Dicitrinone B, Penicitrinine A[111,112,113]
Penicillium sp.JMF034sediment (depth 1151 m)Suruga Bay (Japan)Gliotoxin, Gliotoxin G, 5a,6-Didehydrogliotoxin, 6-Deoxy-5a,6-didehydrogliotoxin, Bis(dethio)-10a-methylthio-3a-deoxy-3,3a-didehydrogliotoxin, Bis(dethio)bis(methylthio)gliotoxin, Bis(dethio)bis-(methylthio)-5a,6-didehydrogliotoxin[114]
P. brevicompactumLF259S T. aurantiumLimsky Canal (Croatia)Mycophenolic acid[98]
P. citreovirideLF590S T. aurantiumLimsky Canal (Croatia)Citreoviridins, Territrem B[98]
P. canescens
(Penicillium sp.)		LF596S T. aurantiumLimsky Canal (Croatia)Griseofulvin, Fiscalin A–C, Tryptoquivalin, Nortryptoquivalin[98]
P. sclerotiorumLF607S T. aurantiumLimsky Canal (Croatia)Sclerotiorin, Sclerotioramin, Azaphilone derivative (comp. D)[98]
Penicillium sp.J05B-3-F-1S Stelletta sp.Jeju Island (Korea)(3S)-Hexylitaconic acid, (3S,8R)-Methyl 8-hydroxy-3-methoxycarbonyl-2-methylenenonanoate, (3S,8R)-8-Hydroxy-3-carboxy-2-methylenenonanoic acid, (3S)-9-Hydroxy-3-carboxy-2-methylenenonanoic acid, (3S)-Methyl-9-hydroxy-3-methoxycarbonyl-2-methylenenonanoate[115]
P. paneumSD-44sediment (depth 20 m)South China SeaPenipanoid A–C, 2-(4-Hydroxybenzyl)quinazolin-4(3H)-one,
Penipacid A–E, Penipaline A–C, (−)-(3S)-2,3,4,9-Tetrahydro-1,1-dimethyl-1H-β-carboline-3-carboxylic acid, 1,7-Dihydro-7,7-dimethylpyrano[2,3-g]indole-3-carbaldehyde		[116,117,118]
P. communeQSD-17sedimentSouth China SeaMeleagrin, Asperamide B1, Citreohybridonol, 3-Deacetylcitreohybridonol, Comazaphilone A–F, Isophomenone, Conidiogenone B–D,F, Conidiogenol[12,119]
Penicillium sp.DG(M3)6′CC Didemnum granulatumToque Island (Brazil)13-Desoxyphomenone[120]
P. raistrickiiAC(M2)14S Axinella cf. corrugataToque Island (Brazil)Norlichexanthone[120]
P. paxilliMa(G)KS Mycale angulosaToque Island (Brazil)Pyrenocine A–B,J[120]
P. steckiiAS(F)39B Sargassum sp.Toque Island (Brazil)8-Methoxy-3,5-dimethylisochroman-6-ol[120]
Penicillium sp.ghq208sedimentJiaozhou Bay (China)Penicinoline, Penicinoline E, Methylpenicinoline, Quinolactacide[121]
P. pinophilum
(T. pinophilus)		-G Ulva fasciataKasai Marine Park (Japan)Pinophilin A–B, Sch725680[122]
Penicillium sp.fS36S unidentified spongeTakarajima Island (Japan)JBR-113,-114,-115[123]
Penicillium sp.F00120sediment (depth 1300 m)South China SeaPenicilliumin A[9]
Penicillium sp.SOF07sediment (depth 675 m)South China SeaMycophenolic acid, Hydroxy-mycophenolic acid, Penicacid A–C[124]
P. crustosumPRB-2sediment (depth 526 m)Prydz Bay (Antarctica)Penilactone A–B, 2′,4′-Dihydroxy-3′-methoxymethyl-5′-methylacetophenone [125]
P. communeSD-118sedimentSouth China SeaMeleagrin, Chrysogine, Methyl 2-N-(2-hydroxyphenyl)carbamoylacetate, Asperamide A–B, Xanthocillin X, N-(2-Hydroxypropanoyl)-2-amino benzoic acid amide, N-(2-Hydroxyphenyl)acetamide, 4-Hydroxy benzaldehyde, Methyl-2-(2-(1H-indol-3-yl)ethyl)carbamoyl)acetate, N2′-Acetyltryptophan methyl ester, N-Acetyldopamine[126]
P. commune518C Muricella abnormalisDanzhou (Hainan, China)Communol A–G, Clavatol, 2,4-Dihydroxy-3-methylacetophenone, 2,4-Dihydroxy-3-methoxymethyl-5-methylacetophenone, 2,4-Dihydroxy-5-methylacetophenone, cis-Bis(methylthio)silvatin[127]
P. canescensMMS194waterLa Baule (France)Griseofulvin, Dechlorogriseofulvin, Oxaline, Maculosin, Penicillic acid, Penitremone A–C[54]
P. canescensMMS460sedimentLe Croisic (France)Griseofulvin, Dechlorogriseofulvin, Oxaline, Penicillic acid,
Penitremone A–C		[54]
Penicillium sp.MMS747sedimentLa Couplasse (France)Griseofulvin, Dechlorogriseofulvin, Penicillic acid, Nortryptoquivaline, Agroclavine, Festuclavine[54]
P. chrysogenumMMS5M shellfishLe Croisic (France)Meleagrin, Roquefortine C–D, Chrysogine, Aurantioclavine, Maculosin, Glandicolin A–B, Terrestric acid, Verruculotoxin[54]
P. antarcticumMMS14M cocklesLe Croisic (France)Chrysogine, Cladosporin(=asperentin), 5-Hydroxyasperentin, Antarone A, Violaceic acid, Patulin, Terrestric acid[54,128]
P. antarcticumMMS15M cocklesLe Croisic (France)Chrysogine, Cladosporin, 5-Hydroxyasperentin, Aurantioclavine, Antarone A, Patulin, Terrestric acid[54,128]
P. antarcticumMMS163M musselLoire estuary (France)Patulin, Chrysogine, Cladosporin, 5-Hydroxyasperentin, Terrestric acid[128]
P. marinumMMS266M musselLa Baule (France)Penostatin derivatives, Fusoxysporone[128]
P. restrictumMMS417M cocklesLe Croisic (France)Pestalotin, Hydroxypestalotin, 5,6-Dihydro-4-methoxy-6-(1-oxopentyl)-2H-pyran-2-one[128]
P. citrinum-C soft coralVan Phong Bay (Vietnam)JBIR-27, Petasol, Sporogen AO-1, Dihydrosporogen AO-1[129]
Penicillium sp.F011sedimentKoreaHerqueiazole, Herqueioxazole, Herqueidiketal[130]
Penicillium sp.FF001S Melophlus sp.Cicia (Fiji)Citrinin[131]
P. pinophilum
(T. pinophilus)		SD-272sedimentPearl River estuary (China)Pinodiketopiperazine A, 6,7-Dihydroxy-3-methoxy-3-methyl phthalide, Cyclo(d-prolyl-d-valyl), Cyclo(trans-4-OH-d-prolyl-d-phenylalanyl), N-methylphenyldehydroalanyl-l-prolin-anhydrid, l-5-Oxoproline methyl ester, Rubralide C, Alternariol 2,4-dimethyl ether, Altenuene, 5′-Epialtenuene[132]
Penicillium sp.-B Fucus spiralisShetland Islands (Scotland)Patulin, Epiepoformin, Phyllostine, Cladosporin[133]
Penicillium sp.MWZ14-4S unidentified spongeWeizhou (South China Sea)Penicimarin A–F, Penicifuran A–D, Aspergillumarin A–B, Sescandelin-B, 5,6,8-Trihydroxy-4-(1′-hydroxyethyl)isocoumarin[134]
Penicillium sp.SCSIO00258C Dichotella gemmaceaSanya (Hainan, China)Penilloid A, Roquefortine C, Isoroquefortine C, Methoxyroquefortine C, Meleagrin, Glandicoline B, Neoxaline, (Z)-3-(1H-Imidazole-4-yimethylene)-6-(1H-indl-3-ylmethyl)-2,5–piperazinediol[135]
Penicillium sp.SCSGAF0023C D. gemmaceaSanya (Hainan, China)Paecilin C, 6,8,5′6′-Tetrahydroxy-3′-methylflavone, Emodin, Citrorosein, Isorhodoptilometrin, Penicillixanthone A, Secalonic acid B–D[136]
Penicillium sp.SF-5203intertidal sedimentWan Island (Korea)Fructigenine A, Cyclopenol[137]
Penicillium sp.SF-5292Z unidentified BryozoanJeju Island (Korea)Penicillinolide A, Cycloexpansamine A–B[138,139]
Penicillium sp.SF-5295S unidentified spongeJeju Island (Korea)Viridicatol[137]
Penicillium sp.
(P. glabrum)		JF-55S unidentified spongeJeju Island (Korea)Penstyrylpyrone, Anhydrofulvic acid, Citromycetin[140]
Penicillium sp.JF-72S unidentified spongeJeju Island (Korea)Deoxyisoaustamide, Deoxydihydroisoaustamide, 16β-Hydroxy-17β-methoxy-deoxydihydroisoaustamide[141]
P. chrysogenumEN-118B Sargassum pallidumFujian (China)Chrysotriazole A–B, 2-(4-Hydroxybenzoyl)-4(3H)-quinazolinone, 2-(4-Hydroxybenzyl)quinazolin-4(3H)-one), 2-(4-Hydroxyphenyl)acetylamide), N-(2-(4-Hydroxyphenyl)acetyl)formamide, N-(2E)-(4-Hydroxyphenyl) ethenyl)formamide, N-(2Z)-(4-Hydroxyphenyl)ethenylformamide[142]
Penicillium sp.ZLN29sedimentJiaozhou Bay (China)Penicillide, Prenpenicillide, Prenxanthone, Bioxanthracene, NG-011, NG-012, 15-G256α-2, 15-G256β[143]
Penicillium sp.F37S A. corrugataArvoredo Island (Brazil)cis-Cyclo(leucyl-tyrosyl)[144]
Penicillium sp.PR19N-1 = MBC06294sludge (depth 1000 m)Prydz Bay (Antarctica)1-Chloro-3β-acetoxy-7-hydroxy-trinoreremophil-1,6,9-trien-8-one, 1-α-Chloro-2β-hydroxyeremophil-7(11),9-dien-8-one, 1α-Chloro-2β-hydroxyeremophil-7(11),9-dien-8-one, 5 new eremophilane compounds, Eremofortine C[145,146]
P. citrinumSCSGAF167C Echinogorgia aurantiacaSanya (Hainan, China)Penicitrinol G–H, 2,11-Dihydroxy-1-methoxycarbonyl-9-carboxylxanthone, Chrysophanol[147]
P. brefeldianumSD-273sediment (depth 100 m)Pearl River estuary (China)Verruculogen, 24-Hydroxyverruculogen, 26-Hydroxyverruculogen, 13-O-Prenyl-26-hydroxyverruculogen, Fumitremorgin A, Cyclotryprostatin A, TR-2[148]
P. commune366606waterQingdao (China)Penicilliumine[149]
P. echinulatumpt-4R Chondrus ocellatusPingtan Island (China)Arisugacin C,G,J,K, Territrem C[150]
Penicillium sp.F446sediment (depth 25 m)Geomun-do Island (Korea)Penicillipyrone A–B[151]
T. trachyspermusKUFA0021S Clathria reianwardiiKram Island (Thailand)Spiculisporic acid E, Glaucanic acid, Glauconic acid[152]
P. chrysogenumPJX-17sedimentSouth China SeaSorbicathecol A–B, Protocatechuic acid methyl ester, Caffeic acid methyl ester[153]
Penicillium sp.SF-5995C unidentified soft coralTerra Nova Bay (Antarctica)Methylpenicinoline[154]
P. adametzioidesAS-53S unidentified spongeWenchang (Hainan, China)Lapatin A–B, Prelapatin B, N-Formyllapatin A, Glyantrypine, Adametizine A–B, Adametacorenol A–B, Peniciadametizine A–B, Brasiliamide A, Viridicatumtoxin, Fumitremorgin B, Verruculogen[155,156,157]
Penicillium sp.SF-6013U Brisaster latifronsSea of Okhotsk (Russia)Tanzawaic acid A–B,D–E, 2E,4Z-Tanzawaic acid D[158]
P. bialowiezenseIBT28294waterNorth SeaAsperphenamates, Mycophenolic acid, F13459, Andrastin A,
Chrysogeside B–E, Quinolactacin A, Raistrick phenols, Xanthoepocin, Citreohybridonol, Preaustinoids, Fellutamides, Breviones		[159]
P. lividumKMM4663B Sargassum miyabeiLazurnaya Bay (Sea of Japan)Sargassopenilline B–G[160]
P. thomiiKMM4645B S. miyabeiLazurnaya Bay (Sea of Japan)Sargassopenilline A,E[160]
Talaromyces sp.LF458S A. verrucosaElba Island (Italy)Talaromycesone A–B, Talaroxanthenone, Vermixocin A–B, AS-186c, Δ1′,3′,-1′-Dehydroxypenicillide, 1′,2′-Dehydropenicillide, 3′-Methoxy-1′2′-dehydropenicillide[161]
Talaromyces sp.SBE-14C Subergorgia suberosaWeizhou (South China Sea)Talaromycin A-C4, Penicillide,
Δ1′,3′,-1′-Dehydroxypenicillide,Purpactin A,C,C′, Tenellic acid methyl esther		[162]
P. pinophilum
(T. pinophilus)		XS-20090E18C unidentified gorgonianXisha Island (South China Sea)Purpactin A, Penicillide, Isopenicillide, Hydroxypenicillide, Sch1385568, Sch725680, Pinophilin B,D–F, Mitorubrin, Mitorubrinol, Mitorubrinic acid[163]
T. miniolouteusPILE14-5S unidentified spongePhi Phi Island (Thailand)Minioluteumide A–D, Purpuride, Purpuride B, Berkedrimane B[164]
P. claviforme
(P. vulpinum)		KMM4665P Z. marinaPeter the Great Gulf (Russia)3-[2′(R)-Hydroxybutyl]-7-hydroxyphthalide,
(–)-3-Butyl-7-hydroxyphthalide, Isopatulin, Cyclopenin, Cyclopeptin		[165]
P. vinaceumCYE-88S Hyrtios erectusYanbu (Saudi Arabia)Penicillivinacine, Cyclo(d-tryptophanyl-l-prolyl), Citreoisocoumarin, Brevianamide F, Indol-3-carbaldehyde, α-Cyclopiazonic acid, Terretrione A[166]
Penicillium sp.CYE-87T Didemnum sp.Suez Canal (Egypt)Terretrione C–D, Indol-3-carbaldehyde, 3,6-Diisobutylpyrazin-2(1H)-one, Methyl-2-([2-(1H-indol-3-yl)ethyl]carbamoyl)acetate, Tryptamine[167]
Penicillium sp.IO1S Ircinia orosKermer (Turkey)Fusarielin I, Griseofulvin, Dechlorogriseofulvin[16]
Penicillium sp.IO2S I. orosKermer (Turkey)Curvularin, Dehydrocurvularin, Trichodimerol [16]
P. expansumY32waterIndian Ocean, west of SumatraCommunesine A–B,I, Fumiquinazoline Q, Prelapatin B, Penochalasin E, Glyantripine, Protuboxepin A–B,E, Cottoquinazoline A, Chaetoglobosin C[168]
Penicillium sp.KCB12F005sedimentHaenam (Korea)Haenamindole[169]
Penicillium sp.CF07370sediment (depth 100 m)Gulf of California (Mexico)Tanzawaic acid B,E,M–P[170]
Penicillium sp.TPU1271organic debris attached to oysterOshika Peninsula (Japan)Penicyrone A–B, Verrucosidin, Fructigenine A, Verrucofortine, Cyclo(l-Tryptophanyl-l-Phenylalanyl), Cyclopenol, Cyclopenin, Penipratynolene, Aspterric acid, Viridicatol[171]
P. concentricumZLQ-69waterBohai Sea (China)Phenylpyropene B-D,E–F, Pyripyropene A–B,E,O[172]
P. verruculosum
(T. verruculosum)		TPU1311T Polycarpa aurataManado (Indonesia)Verruculide A–B, Chrodrimanins A–B,H[173]
1 Current species name is specified in parentheses if different from the one reported in the original reference; 2 Information concerning the kind of organism is indicated as follows: B = brown alga; C = coral, soft coral; F = fish; G = green alga; M = mollusc; P = Angiosperm plant; R = red alga; S = sponge; T = tunicate; U = urchin; Z = bryozoan; 3 Products originally characterized from the corresponding strain are underlined; 4 Talaromycins A–C have been reported as new products. However, the same name was previously used for compounds with a different structure isolated from terrestrial Talaromyces strains [174,175].
Table
Table 2. Novel compounds produced by marine Penicillium/Talaromyces strains displaying inhibitory properties against mammalian tumor cell lines.
Table 2. Novel compounds produced by marine Penicillium/Talaromyces strains displaying inhibitory properties against mammalian tumor cell lines.
CompoundBioactivityCell Lines AssayedReferences
AcetophthalidinCytostatic (arrest at M phase)tsFT210[37]
3-Acetyl-9,7(11)-dien-7α-hydroxyl-8-oxoeremophilaneCytotoxicA549, BEL-7402[81]
Adametacorenol BCytotoxicNCI-H446[155]
AuranomidesAntiproliferativeK562, ACHN, HepG2, A549[104]
Aurantiomide BCytotoxicHL-60, P388[77]
Aurantiomide CCytotoxicBEL-7402, P388
Breviones F–HAntiproliferativeHeLa[92]
Brevione ICytotoxicMCF-7, A549[93]
Brocaenols A–CCytotoxicHCT-116[49]
Chloctanspirones A–BCytotoxicHL-60, A549[69]
1-Chloro-3β-acetoxy-7-hydroxyl-trinoreremophil-1,6,9-trien-8-oneCytotoxicHL-60, A549[145]
Citrinadin ACytotoxicL1210, KB[57]
Citrinadin BCytotoxicL1210[58]
Citrinal ACytotoxicK562[85]
Comazaphilones D–FCytotoxicSW1990[12]
Communesins A–BCytotoxicP388[29]
Communesins B–DAntiproliferativeU-937, THP-1, NAMALWA, MOLT-3, SUP-B15[51]
Conidiogenone BCytotoxicBEL-7402, HL-60[88]
11′-Deoxyverticillin A, 11,11′-Dideoxyverticillin ACytotoxicHCT-116[43]
Dihydrotrichodimerol, TetrahydrotrichodimerolCytotoxicP388, A549[66]
(2E,4E)-1-(2,6-Dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-oneCytotoxicHeLa, SW620[97]
3,4-Dihydroxy-4-(4′-methoxyphenyl)-3,4-dihydro-2(1H)-quinolinoneCytotoxicSKOV-3[61]
EpolactaeneCytostatic (arrest at G0/G1 phase)SH-SY5Y[204]
Fellutamides A–BCytotoxicP388, KB[28]
Formylanserinone B, Epoxyserinone BCytotoxicL1210, C38, CFU-GM, H116, H125, MDA-MB-435[53]
Gliotoxin derivativesCytotoxicP388[114]
HerqueidiketalCytotoxicA549[130]
JBIR-28CytotoxicHeLa[82]
LigerinAntiproliferativeOSRGa, POS1, AT6-1, L929[56]
Meleagrin BCytotoxicBEL-7402, HL-60, A549, MOLT-4[88]
Pro-apoptoticHL-60[89]
Meleagrins D–ECytotoxicA549[89]
MinioluteumidesCytotoxicHepG2[164]
Penicacid AAntiproliferativeMouse splenocytes[124]
Penicilliumin ACytotoxicA375, B16, HeLa[9]
PenicillivinacineAntimigratoryMDA-MB-231[166]
Penicillones A–BCytotoxicP388, A549[68]
Penicillone ACytotoxicSW620[97]
Penicisteroid ACytotoxicHeLa, SW1990, NCI-H460[108]
Penicitide ACytotoxicHepG2[107]
Penicitrinine AAntiproliferative, pro-apoptotic23 tumor cell lines[111]
Penicitrinols C, ECytotoxicHL-60[112]
Penipacids A, ECytotoxicRKO[117]
Penipalines B–CCytotoxicA549, HCT-116[118]
Penipanoid ACytotoxicSMMC-7721[116]
Penochalasins A–HCytotoxicP388[30,34]
Penostatins A–C,E–ICytotoxicP388[31,32,33]
Perinadine ACytotoxicL1210[59]
Phenylpyropene ECytotoxicMGC-803[171]
PinophilinsAntiproliferativeA549, BALL-1, HCT116, HeLa, NUGC-3[122]
PrenpenicillideCytotoxicHepG2[143]
Pyrenocine ECytotoxicP388[40]
Sargassopenilline ECytotoxicCD-1[160]
ShearininesPro-apoptoticHL-60[74]
Sorbicillactones, Sorbivinetol, SorbivinetoneCytotoxicL5178y[62]
Tanzawaic acidsAntiproliferative, pro-apoptoticK562, U937, Jurkat, Raji[170]
Terrestrols A–HCytotoxicBEL-7402, HL-60, A549, MOLT-4[64]
Terretrione DAntimigratoryMDA-MB-231[167]
Table
Table 3. Novel antibiotic compounds produced by marine Penicillium/Talaromyces strains.
Table 3. Novel antibiotic compounds produced by marine Penicillium/Talaromyces strains.
CompoundBioactivityMicrobial Species AssayedReferences
Adametizine AAntibacterialAeromonas hydrophila, Staphyloccocus aureus, Vibrio harveyi, Vibrio parahaemolyticus[155]
AntifungalGaeumannomyces graminis
Arisugacin KAntibacterialEscherichia coli[150]
CillifuranoneAntibacterialXanthomonas campestris[98]
AntifungalSeptoria tritici
ComazaphilonesAntibacterialBacillus subtilis, Pseudomonas fluorescens, S. aureus m.r.[12]
Communol A, F–GAntibacterialEnterobacter aerogenes, E. coli[127]
Conidiogenone BAntibacterialPseudomonas aeruginosa, Pseudomonas fluorescens, S. aureus m.r., Staphylococcus epidermidis[109]
AntifungalCandida albicans
Dictyosphaeric acid AAntibacterialEnterococcus faecium, S. aureus, S. aureus m.r.[50]
AntifungalC. albicans
IsocyclocitrinolsAntibacterialEnterococcus durans, S. epidermidis[48]
PeniciadametizinesAntifungalAlternaria brassicae[156]
Penicifuran AAntibacterialBacillus cereus, Staphylococcus albus[134]
PenicilactoneAntibacterialS. aureus m.r.[95]
PenicimonoterpeneAntifungalA. brassicae, Aspergillus niger, Fusarium graminearum[107,214]
AntibacterialA. hydrophila, E. coli, Micrococcus luteus, S. aureus, V. harveyi, V. parahaemolyticus[214]
Penicisteroid AAntifungalA. brassicae, A. niger[108]
Penicitide AAntifungalA. brassicae, A. niger[107]
Penicyclones A–EAntibacterialS. aureus[91]
Perinadine AAntibacterialB. subtilis, M. luteus[59]
Pinodiketopiperazine AAntibacterialE. coli[132]
Scalusamide AAntibacterialM. luteus[60]
AntifungalCryptococcus neoformans
Talaromycesones AntibacterialS. aureus m.r., S. epidermidis[161]
Terretrione DAntifungalC. albicans[167]
Xestodecalactone BAntifungalC. albicans[47]
m.r.: Methicillin resistant.

Share and Cite

MDPI and ACS Style

Nicoletti, R.; Trincone, A. Bioactive Compounds Produced by Strains of Penicillium and Talaromyces of Marine Origin. Mar. Drugs 2016, 14, 37. https://doi.org/10.3390/md14020037

AMA Style

Nicoletti R, Trincone A. Bioactive Compounds Produced by Strains of Penicillium and Talaromyces of Marine Origin. Marine Drugs. 2016; 14(2):37. https://doi.org/10.3390/md14020037

Chicago/Turabian Style

Nicoletti, Rosario, and Antonio Trincone. 2016. "Bioactive Compounds Produced by Strains of Penicillium and Talaromyces of Marine Origin" Marine Drugs 14, no. 2: 37. https://doi.org/10.3390/md14020037

APA Style

Nicoletti, R., & Trincone, A. (2016). Bioactive Compounds Produced by Strains of Penicillium and Talaromyces of Marine Origin. Marine Drugs, 14(2), 37. https://doi.org/10.3390/md14020037

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop